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ABSTRACT
GABA AS A PUTATIVE NEUROTRANSMITTER IN THE 
OPTIC LOBES OF THE CRAB HEMIGRAPSUS NUDUS
Carol L Fulenwider
Gamma-aminobutyric acid ( GABA ) is a widely occurring inhibitory 
neurotransmitter in vertebrate and invertebrate neural tissue. To explore the 
role of GABA as a putative neurotransmitter in the optic lobes of the crab 
Hemigrapsus nudus , light microscope autoradiography ( LM ARG ), light 
microscope immunocytochemistry ( LM ICC ), and neurochemical techniques 
were employed. ARG labeling of 3H-GABA was observed over specific 
neuronal cell bodies and axon fibers in the two outer optic neuropils, the lamina 
ganglionaris and the medulla externa. Biochemical analysis of 3H-GABA 
uptake revealed little surface receptor binding as picrotoxin and bicuculline did 
not appear to effect uptake. Similar biochemical experiments showed little glial . 
involvement. 2,4-diaminobutyrate ( L-DABA ), shown in other studies to 
preferentially inhibit uptake by neurons but not glia, matched the degree of 
inhibition of uptake seen by unlabeled GABA, which affects uptake by neurons 
and glia equally. p-Alanine, which has the reverse effect of L-DABA, reduced
uptake only slightly more than seen in untreated eyes. Hence, ARG labeling 
was primarily intracellular and confined to neurons.
LM ICC staining of GABA was found in specific neurons in the same 
regions of the neuropils which tested positive by ARG. In addition to verifying 
the presence of endogenous GABA, ICC findings support the assumption that 
uptake of exogenous GABA occurs in cells that contain and presumably use 
that transmitter.
Neurochemical analysis of uptake describe a high-affinity, sodium- 
dependent, metabolically active process, findings similar to uptake mechanisms
described for GABA in vertebrate central nervous system and retinal tissue. 
Release of label from preloaded eyes was effected in a dose-dependent 
manner using high concentrations of potassium. Neither uptake nor release 
appeared to involve the cytoskeletal elements actin or tubulin as cytochalasin B 
and colchicine did not effect either process.
Results described above establish GABA as a putative neurotransmitter 
in the optic lobes of the eye of Hemigrapsus nudus. Demonstration of the 
presence of endogenous GABA in specific neurons, uptake of 3H-GABA into 
specific neurons by a high-affinity, sodium-dependent, metabolically active 
process, and demonstration of release of 3H-GABA satisfy half of the criteria for 
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Neurotransmitters are chemical agents that operate at chemical 
synapses to relay information from a neuron to its target organ or between 
neurons. In the early 1950's only four compounds had been identified as 
neurotransmitter substances: acetylcholine, norepinephrine, dopamine, and 
serotonin. At that time these four compounds were thought to represent the full 
array of chemical mediators operating in the central and peripheral nervous 
systems and did not appear to be involved in any other biochemical processes. 
Their distribution was assumed to be restricted to synaptic terminal release sites 
where they were concentrated in small quantities.
During this same decade, however, five amino acids (taurine, glycine, 
gamma-aminobutyric acid, glutamate and aspartate ) were shown to be 
neuroactive. Unlike the chemical agents listed above, these substances were 
universal cellular constituents and present in high concentrations. In addition, 
the activities of these five amino acids were not confined to synaptic mediation 
but included intermediary metabolism.
By the 1970's an entirely new category of neurotransmitter candidates 
had been established, the neuropeptides. Presently representing the largest 
class of neuroactive agents, these small peptide molecules contain 3 to 
approximately 100 amino acid residues and include the neurohormones.
Having restricted distribution and low concentrations, neuropeptides are more 
like the early compounds than amino acidergic systems.
In addition to the many chemicals that have been shown to be 
neuroactive, a new functional category of neuromodulators has been identified, 
compounds which modify the effect of the primary neurotransmitter. Linked to 
second messenger systems, the effects of neuromodulation can be either pre- 
or postsynaptic, can influence many aspects of neuronal functioning, and are 
longer lasting than that of classical neurotransmitters. See Table 1 for a list of 
some neuroactive substances.
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Table 1. List of some neuroactive substances from vertebrate and 
invertebrate nervous systems.
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the same neuron, have also been described. This mechanism apparently 
exists to allow neurons to release a blend of neurotransmitter substances, thus 
enriching the possibilities of action. Neuropeptides are often involved and are 
co-localized with other neurotransmitters such as acetylcholine, GABA, 
dopamine, or other neuropeptides.
Principle Processes Acting at the Synapse
Neurons communicate through chemical and electrical events. Electrical 
synapses ( gap junctions ) are comparatively rare, were not the subject of study 
in this research project and will not be discussed further. The activity of a 
chemical mediator, however, was the object of research and a general scheme 
of chemical synaptic processes is described as follows in two parts, presynaptic 
events and postsynaptic events.
I. Presynaptic Events.
The general scheme of neurotransmitter release is the accumulation of 
significant observations made over 40 years of research. In the 1950's the 
quanta! hypothesis was developed by Katz and associates upon mathematical 
analysis of microelectrode recordings at the neuromuscular synapse ( Fatt 50, 
52; DelCastillo 54, 56 ). Postsynaptic action of acetylcholine ( Ach ) appeared to 
be "quantal” in nature and spontaneous release, miniature end plate potentials 
( MEPP's ), and calcium-mediated release, end plate potentials ( EPP's ), were 
multiples of constant units. The theory was proposed that Ach was released in 
packets or quanta which activated thousands of channels in the end plate. The 
quantal theory was strengthened by observations of vesicles in electron 
micrographs of the neuromuscular synapse, giving rise to the vesicular 
hypothesis, an extension of the original quantal hypothesis stating that synaptic 
vesicles contain this quantum ( DeRobertis 55 ).
Other evidence lends support to the vesicle/quantal hypothesis. For 
example, isolated vesicles have been shown to contain neurotransmitter 
(Whittaker 64), and recently, uptake mechanisms for several transmitters by
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synaptic vesicles have been described, including uptake of GABA ( Hell 88 ). 
Also, morphological studies from electron micrographs have described 
exocytotic profiles or depressions in presynaptic membrane ( Couteaux 70 ). 
Freeze-fracture studies have reported dimples or pits in the outer surface of the 
inner leaflet of presynaptic membrane ( Heuser 78 ), both sets of data proposing 
to have caught vesicles in the act of releasing their contents. In addition, quick- 
freeze experiments have demonstrated quantal release occurring at the same 
time as vesicle-synaptic membrane fusion ( Heuser 79, Torri-Telli 85 ).
In addition to the vesicular nature of transmitter release, much research 
has been devoted to understanding the role of calcium in mediating release. 
First advanced by Katz and associates, calcium has maintained its position as 
the central molecular trigger. Freeze-fracture studies by Dryer ( 73 ) and Peper 
( 74 ) showed double rows of large intramembranous particles at the "active 
zone", suggesting the presence of voltage-gated calcium channels located near 
transmitter release sites. Convincing evidence of calcium influx occurring with 
depolarization has been demonstrated using the luminescent dye aequorin at 
the squid giant synapse ( Llinas 81 ).
The current hypothesis of calcium-mediated vesicular release can be 
summed up in the following way. The arrival of an action potential at the 
presynaptic terminal causes a transient ( on the order of a msec ), local influx of 
calcium through voltage-sensitive calcium gates located near but not at 
transmitter release sites ( Hubbard 68, Zuker 86 ). The increase in free cytosolic 
calcium at the presynaptic membrane triggers fusion of synaptic vesicles with 
the presynaptic membrane and release of quanta of transmitter into the 
synaptic cleft, a process called exocytosis ( Hueser 79, Kelly 79 ). Rapid 
inactivation of calcium channels and removal of the calcium pulse by calcium 
pumps, buffering and sequestration mechanisms, such as calmodulin, 
calcineurin, and smooth endoplasmic reticulum, terminate exocytosis ( Chad 
89, Miller 88).
The following sections will discuss in more detail the molecular events 
associated with an endocytotic-exocytotic cycle: fusion of synaptic vesicle
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membrane with presynaptic membrane, transmitter release, and retrieval of 
vesicle membrane. It is worth noting here that calcium acts at each level of 
control, coordinating a multiplicity of spatially distributed functions associated 
with release.
i. Protein Kinases and Their Substrates. A major unknown in the 
mechanism of vesicular exocytosis is the molecular cascade linking calcium 
influx with fusion of vesicular membrane to postsynaptic membrane. The 
search for calcium agents has generated a large volume of literature in two 
areas: synaptic vesicle and cytoskeletal proteins and second messenger 
systems acting on these proteins. Research regarding vesicle proteins is 
predicated on evidence that vesicular membrane proteins enable synaptic 
vesicles to fulfill their major tasks during their life cycle. These tasks are uptake 
of molecules and neurotransmitter, interaction with cytoskeleton during 
antegrade and retrograde transport, anchorage inside the nerve terminal, and 
interaction with presynaptic membrane during exocytosis and endocytosis. 
Cytoskeletal proteins are studied as these molecules interact with vesicular 
proteins during many of the events listed in a vesicle's life cycle.
The second area of study on mechanisms of exocytosis, second 
messenger systems, has been prompted by two observations. The first 
observation was that with depolarization of neurons protein phosphorylation in 
the synaptic terminal increases significantly ( Robinson 87 ). The second 
observation, the activation of kinases by calcium, led to the investigation of 
calcium-mediated enzyme systems and vesicular and cytoskeletal protein 
targets. Particular proteins and enzymes actively studied were: the synapsins, 
synaptophysin, VAMP-I, actin and actin-binding proteins, tubulin and tubulin- 
associated proteins, clathrin and clathrin-associated proteins, magnesium- 
activated ATPase, protein kinases (c-AMP, c-GMP, Ca+2 dependent), 
calmodulin, Ca+2-dependent membrane-binding proteins ( calelectrin ), and 
phospholipases ( Walker 87, Kennedy 83 ).
A model that has emerged for the mechanism of neurotransmitter release 
begins with synaptic vesicles transported by microtubules from their site of
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synthesis and anchored at the axon terminal within a highly organized 
cytoskeletal network ( Aunis 88, Gray 83 ). This network, composed of actin, 
tubulin, their polymers ( microfilaments and microtubules, respectively ), 
neurofilaments, and associated binding proteins (fodrin, vinculin, gelsolin, and 
caldesmon ), interacts with specific vesicular proteins ( synapsin I, clathrin ) to 
cross-link vesicles with each other and to synaptic membrane (Hirokawa 89, 
Landis 88, Bray 81 ). Thus, this filamentous network acts as a docking system 
to position and concentrate vesicles in close apposition to presynaptic 
membrane and acts as a barrier to limit diffusion and prevent exocytosis 
( Schafer 87, Aunis 88 ).
The model proposes that the transient increase in cytosolic calcium 
derived from an action potential activates calcium-dependent enzymes which 
phosphorylate one or more vesicle- and cytoskeletal-associated proteins, 
causing molecular rearrangement of the cytoskeleton ( Bernstein 85, Burgoyne, 
87 ). The literature favors a calcium/calmodulin-dependent protein kinase II 
phosphorylation of synapsin I in association with rearrangement of F-actin 
( Llinas 85, Bernstein 89 ). The effect of this calcium-induced reorganization of 
cytoskeleton is to release vesicles from their docking sites, allowing free 
diffusion and interaction with synaptic membrane ( DeCamilli 86 ).
ii. Mechanism of Vesicle Fusion. Fusion of closely opposed membranes 
is an exceptional event under strict control, confined to specific membrane pairs 
( Rand 86 ). Given this knowledge, the exocytotic event must involve more than 
vesicle availability to synaptic membrane. Some authors suggest that 
membrane fusion is the result of neutralization of negative charges on the inner 
surface of plasma membrane and outer surface of vesicle membrane by 
calcium ( Blioch 68, Papahadjopoulos 78 ). This model has fallen out of favor 
due to the lack of selectivity of divalent binding to surface charges and due to 
the high concentration of divalent ion required to initiate membrane fusion 
( Heuser 79 ).
Others support the role of osmotic forces as the driving force for exocytosis 
( Finkelstein 86, Holz 86 ). According to this theory, swelling of synaptic
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vesicles resulting from an influx of potassium through calcium-activated 
potassium channels leads to membrane destabilization. However, recent data 
has shown that in mast cells swelling of vesicles follows rather than precedes 
fusion ( Zimmerman 87 ).
Breckenridge ( 87 ) describes an aqueous Hfusion poreM formed upon 
binding of vesicle to synaptic membrane, as measured by a stepwise increase 
in membrane capacitance ( Cm). Preceding exocytosis, a "flicker" in Cm can be 
observed and is interpreted as repetitious opening and closing of vesicles 
before a wider and permanent connection is established. Thus membrane 
fusion appears to begin at localized areas where pores in the fusing 
membranes are seen. Based on this concept, other research describes 
synaptic membrane and vesicular ionic channels, similar in many properties, 
acting in concert to form a gap-junction-like pore ( Rahamimoff 
89 ). It has been proposed that this pore formation is regulated by 
synaptophysin ( p38), a synaptic vesicle integral membrane glycoprotein that 
binds calcium ( Wiedenmann 85, DeCamilli 88 ). The concluding event, access 
to the synaptic cleft by vesicular contents, is the same for each theory.
iii. Endocytosis. The fate of vesicular membrane after, as well as during 
exocytosis is somewhat controversial. The gap-junction-like pore is seen by 
some to represent a transient opening in the synaptic vesicle followed by 
vesicle removal from the active zone, while others support vesicular collapse 
and incorporation of vesicular membrane contents and mass into synaptic 
membrane ( Meldolesi 81, Heuser 89 ). The latter theory is strengthened by 
many papers. Reports on horseradish peroxidase uptake after nerve excitation 
show the marker occurring first in coated vesicles and cisternae, rather than in 
synaptic vesicles, suggesting retrieval by the pathway of protein endocytosis 
( Hueser 73 ). Other experiments show a transient increase in plasma 
membrane surface area after nerve stimulation, measured 
electrophysiologically as an increase in membrane capacitance 
( Fernandez 84 ). Still other researchers have traced synaptic vesicle antigens 
in plasma membrane following excitation ( vonWedel 81 ).
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In summary, the general theory of exocytosis involves a tightly regulated 
process beginning with direction specific transport and site specific, protein 
targeted docking of vesicles. Calcium mediated removal of constraint on 
vesicle movement allows vesicles access to and recognition of fusion sites. 
Vesicle fusion to synaptic membrane and pore formation are followed by 
transmitter discharge, ending with collapse and recycling of vesicle membrane 
through coated vesicles for re-use for another exo-endocytotic cycle ( Ceccarelli 
80, Reichart 83 ). As in the case of exocytosis, endocytosis and recycling do not 
occur at random but are under strict control by calcium ( Ceccarelli 80 ) ( see 
Figure 1 ).
II. Postsynaptic Events.
After diffusion across the cleft, neurotransmitter binds to specific 
postsynaptic receptors on target neurons, exerting a brief excitatory or inhibitory 
change in postsynaptic membrane potential. This signal occurs by one of two 
types of coupling between transmitter and receptor. In the direct type, the 
receptor is part of an ion channel or gate which, when bound to its specific 
ligand, undergoes conformational change to open the channel. The open state 
is very brief to an individual or small species of ions. Normally the channel is in 
the closed conformation.
In the second type of signaling, the receptor is coupled with a second 
messenger system. For example, if the receptor is linked to G protein, binding 
of ligand initiates a classical cascade of events in which activated G protein 
stimulates specific membrane enzymes ( e.g., adenylate cyclase and 
phospholipase C ) which generate soluble intracellular messengers 
( kinases ). Kinase targets include enzymes, cytoskeletal elements, pumps and 
transporters, as well as ion channels. Phosphorylation of ion channels 
modulates the frequency of channel opening and closing rather than the on-off 
effect seen in the direct type channel. Because of the cascade of steps leading 
to phosphorylation, the agonist action is amplified, is delayed by several msec, 










cytosis• m<3o° o°^(5) release ?
jcz - • —:00
i I(4) Ca . ••• 




(7a) second (7b) ionophore 
messengers postsynaptic
neuronV y
Figure 1. Transmitters are (1) synthesized from precursors and (2) 
stored in vesicles or cytoplasm. An (3) action potential arriving at the 
terminal will cause (4) an influx of calcium which (5) triggers the 
release of transmitter into the cleft. After diffusing across the cleft, 
transmitter will (6) bind to specific receptors and alter membrane 
potential via (7a) second messenger systems or (7b) ionophores. 
Termination of transmitter effect occurs by (8) reuptake or enzymatic 
hydrolysis, while vesicle membrane is recycled by (9) endocytosis. 
Adapted in part from Bradford, 86.
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Neurotransmitter action is terminated by enzymatic degradation of the 
molecule or by diffusion and reuptake into the presynaptic neuron and 
surrounding glia. In the case of second messenger systems, deactivation of G 
proteins and dephosphorylation of protein kinases by phosphatases is the final 
link to transmitter inactivation.
III. Alternate Models of Exocytosis.
Although there is strong evidence for calcium-mediated vesicular 
exocytosis as the mechanism for transmitter release, the theory is not free of 
controversy. Many experiments show calcium-independent transmitter release 
as well as non-vesicular release, implying alternate mechanisms of transmitter 
release as well as alternate pools of releasable transmitter.
For example, cytoplasmic acetylcholine is present in significant amounts 
within the motoneuron terminal and can be released. Upon stimulation, these 
nonvesicular pools are released first ( Suszkiw 78 ). In addition, enzymatic 
digestion of extravesicular pools inhibits synaptic transmission ( Hurcho 78 ). 
The Membrane Gate Model proposed by Dunant ( 85 ) involves a protein 
embedded in the membrane that acts as a valve. A change in protein 
configuration allows the transmitter to pass through.
Other studies show that membrane potential is important for transmitter 
release. It is suggested that presynaptic depolarization resulting from an action 
potential not only allows calcium influx, but also acts on the presynaptic 
secretory machinery independently and directly to release transmitter ( Parnas 
88, Zucker 86 ). Recently this hypothesis has come into question (Zuker 88 ).
Evidence for calcium-independent exocytosis is also intriguing. Using two 
techniques, Gompers ( 88 ) was able to demonstrate secretion from 
permeabilized mast cells. In the first technique, the calcium-ionophore 
( A23187 ) was used to increase cytosolic calcium and cause secretion. In the 
second technique, GTP or its non-hydrolyzable analogs ( GTPgS or GppNHp ) 
stimulated secretion with no increase in cytosolic calcium. When used together 
the effect of the two mediators is additive, suggesting a dual effector system.
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Other researchers implicate the role of protein kinase C in secretion. In 
permeabilized chromaffin cells and platelets, activators of protein kinase C 
( phorbol esters, diacylglycerol) can cause secretion while cytosolic calcium 
remains at resting concentrations ( Knight 87, Rink 83 ). The interesting 
possibilities suggested by these experiments are that alternate pathways for 
transmitter release exist either as parallel, independent pathways or as 
converging pathways, or that the calcium pathway can be modified by other 
second messenger systems ( GTP, protein kinase C ). Owing to the numerous 
functions associated with release and the large number of phosphorylating 
systems concentrated at the synapse, it is difficult to determine whether 
experiments reveal mediator or modulator effects on transmitter release. 
Indeed, this is a central problem in interpretation of data concerned with 
classical as well as non-classical release mechanisms. It is important to note 
that observations concerning alternate mechanisms of release arise from 
experiments on cells other than central nervous system neurons and the 
secretory cascade may not be identical in different cells.
Identification of a Substance as a Neurotransmitter
In order for a substance to be established as a neurotransmitter the 
following set of requirements must be met ( Erulkar 89 ). Where the criteria 
is only partially satisfied, the substance is given the status of putative rather than 
classical neurotransmitter.
1. Localization. The substance is shown to be contained in the neurons 
from which it is released.
Precursors, synthetic and degradative enzymes can be 
identified in neurons using the neurotransmitter. 
Calcium-dependent release of neurotransmitter into 




The local tissue possesses mechanisms for 
terminating the effect of the molecule.
Receptors on postsynaptic membrane can be 
demonstrated in local tissue as well as a 
physiological response to receptor-ligand binding. 
6. Pharmacology. Pharmacological agents that act as agonists can
mimic the effect of the substance at the synapse and 




Immunohistochemistry is a powerful and popular technique for localization 
of neurotransmitter ( criteria 1 ) or enzymes ( criteria 2 and 4 ). In this method 
antibodies are raised in an animal (rabbit) against the molecule to be identified 
( neurotransmitter or enzyme ). Antiserum containing the antibodies is applied 
to the tissue under investigation and the antibody binds to the particular 
antigen. The antibody, and indirectly the antigen in the tissue, is made visible 
under a microscope by several techniques. In the direct immunocytochemistry 
(ICC ) procedure the primary antibody is labeled (fluorescent or radioactive 
tag ). In the more sensitive indirect ICC method, the primary antibody is 
visualized with a labeled secondary antibody (fluorescence, radioactivity, or 
dye ). Sandwich techniques use a third layer in which the secondary antibody 
is linked to the primary antibody and to a stain-producing complex, such as 
peroxidase-antiperoxidase ( PAP ) or avidin-biotin.
The most recent technique for antigen localization, in situ hybridization, 
uses probes that are specific for mRNA. The retroviral enzyme reverse 
transcriptase is used to copy mRNA into complementary DNA ( cDNA ). These 
cDNAs hybridize specifically to complementary mRNA molecules; thus the 
cDNAs can be labeled and hybridized to mRNA that is present in cells in situ. In 
situ hybridization has been particularly successful in localizing the mRNAs for 
peptide transmitters.
Autoradiography ( ARG ), an older technique, is used to localize 
radiolabeled neurotransmitter that has been taken up into specific nerve
13
terminals by high-affinity transport. This is based on the concept that only those 
neurons which release a particular neurotransmitter will have reuptake systems 
for that transmitter, a process which functions to terminate neurotransmitter 
action and to conserve neurotransmitter for reuse.
Criteron 3 (release ) is evaluated using an electrical or chemical 
depolarizing stimulus. Usually, neurotransmitter release is measured indirectly 
by making radiographic counts of perfusates of in vitro tissue preloaded with 
radiolabeled neurotransmitter. More recently, release of endogenous 
neurotransmitter has been measured by high performance liquid 
chromatography ( HPLC ).
Detection and characterization of postsynaptic effects ( criteria 5 and 
6 ) involve the study of two processes, receptor recognition and binding to a 
site, and transduction of this information into a response signal. Early studies 
evaluated the second process by electrophysiologic techniques, i. e., 
iontophoretic application of the neurotransmitter, agonists or antagonists 
coupled with either extra- or intracellular recordings to detect changes in 
membrane potential. Presently, in vitro biochemical studies are used to 
characterize receptor-ligand binding, the first process. Visualization of 
receptors at the light and electron microscopic level for the generation of 
receptor maps are achieved by ARG of radiolabeled transmitter or ligands 
( drugs ) and by ICC techniques using antibodies raised against receptors 
( Richards 87).
The molecules satisfactorily meeting the criteria listed above are 
referred to as classical neurotransmitters. Included are acetylcholine, GABA, 
the catecholamines norepinephrine and dopamine, and the indole amine 
serotonin. Other molecules such as adenosine, epinephrine and histamine are 
unquestionably neuroactive but less information is available concerning the 
neurotransmitter role of these compounds.
GABA as a Neurotransmitter
GABA is one of the most thoroughly documented neurotransmitters. First
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reported in 1883 ( Schotten ), GABA metabolism was subsequently studied in 
fungi, yeast, and plants but was not recognized in neurological tissue until 
1950, when three labs almost simultaneously isolated GABA from mammalian 
brain ( Roberts 50, Udenfriend 50, Awapara 50 ). Initially thought to be a 
metabolite in the glutamic acid cycle, GABA's role as an inhibitory 
neurotransmitter was first demonstrated by Florey ( 54 ) and confirmed by 
Kuffler and Edwards ( 58 ). Extracts from lobster nervous system were tested 
for inhibitory activity on stretch receptor neurons. Of the eight amino acids 
isolated and tested, only GABA showed a high degree of potency. Wiersma 
( 52 ) located inhibitory and excitatory neurons in crustacean leg muscle and 
GABA was found to be preferentially distributed in inhibitory neurons. In 
addition, GABA was present in the axon in surprisingly high concentrations 
(10 p.M ), six times more concentrated than in the cell body. Finally, perfusates 
of a claw muscle stimulated by an inhibitory neuron were found to contain 
GABA ( Otsuka 66 ). Thus the presence of GABA in the axon, its asymmetry of 
distribution to inhibitory neurons, and the physiological effect on crustacean 
neuromuscular junctions were convincing evidence for the role of GABA as an 
inhibitory neurotransmitter.
Later an important work on specifically identified neurons in mammalian 
brain was performed by Otsuka and Obuta ( 71 ). They examined Purkinje cells, 
whose axons represent the entire output of the cerebellar cortex and form 
inhibitory synapses on several distinct nuclei. Enzymatic assays of Purkinje 
cells and the lateral vestibular nucleus of Deiters contained concentrations of 
GABA higher than controls. Cutting Purkinje cell axons reduced the level of 
GABA in Deiters' nucleus, suggesting that GABA normally isolated there was 
derived from synapses upon the nucleus and not the nucleus itself. This 
reinforced the idea that GABA may be highly concentrated in terminals that use 
the neurotransmitter.
Fonnum ( 73 ) and coworkers demonstrated that cutting Purkinje cells also 
resulted in the disappearance of glutamic acid decarboxylase ( GAD ), the 
synthesizing enzyme, from the terminal. Robert's team ( 78 ) later purified GAD
15
developed antibodies and demonstrated by IHC technique the presence of the 
enzyme in specific neuronal elements. Other physiological evidence from 
intracellular recordings in Deiters' nucleus showed that iontophoretic 
application of GABA mimiced electrical stimulation.
Several lines of evidence suggested the role of GABA as an inhibitory 
transmitter, first in invertebrate crustacean neurons and later in mammalian 
Purkinje cells. Subsequently GABAergic neurons and pathways have been 
identified in many species. Further research has generated extensive data 
describing GABA metabolism, receptor physiology and pharmacology, release 
and uptake, all of which have established GABA as a classical transmitter.
Distribution of GABA in mammalian brain
The amino acids appear to be the best candidates for chemical synaptic 
mediation of rapid transient excitatory and inhibitory actions in the cerebral 
cortex ( Snyder 76 ). Glutamic and aspartic acids are universally excitatory and 
GABA is the major, if not only, generally active inhibitory substance. All other 
neuroactive substances found in the cortex have slower and longer-lasting 
effects, functioning as neuromodulators.
GABA is widely distributed in virtually every brain region and it has been 
suggested that 40% of all neurons use GABA ( Edelman 82). GABA is thought 
to be the transmitter used by interneurons, small neurons which project locally 
and generally form basket-type endings around the perikarya of other neurons 
( Steward 89 ). GABA-containing synapses also terminate upon axon initial 
segments and upon dendritic shafts. In most CNS locations the GABAergic 
synapses form type II ( symmetric) synapses, having flattened vesicles. 
Examples of interneurons are Purkinje, basket, and Golgi cells in the 
cerebellum, horizontal and amacrine cells in the retina, and Renshaw cells in 
the spinal cord.
Information on GABAergic pathways has been collected by multilevel 
analysis, primarily by IHC using antibodies to GABA and GAD, supplemented 
by studies of lesions, axoplasmic flow, 3H-GABA uptake and release, and ligand
16
receptor binding maps. GABA as an inhibitory transmitter is found in the brain 
spinal cord and retina but not in the peripheral nerves. More specific areas of 
the CNS which are commonly listed as using GABA are: the cerebral cortex, 
especially cortical layer IV, spinal cord dorsal horn, retinal horizontal and 
amacrine cells, hippocampus, thalamus and hypothalamus, olfactory bulb, 
cerebellar Golgi, basket, stellate, and Purkinje cells, amygdala, septal area, 
neostriatum, n. accumbens, inferior colliculus, raphe n., lateral geniculate n., 
cochlear n., basal ganglia ( caudate, putamen, globus pallidus, substantia 
nigra ).
GABA and its proposed relation to various clinical states.
A large body of evidence links altered GABAergic function with neurologic 
and psychiatric disorders in humans. Diseases most often mentioned are 
epilepsy ( Kamphuis 90, Roberts 86 ) and anxiety ( Matsumoto 89 ) followed by 
Huntington's chorea, tardive dyskinesia, depression and schizophrenia 
( Matsumoto 89, Deniker 79 ). Pharmacological data most clearly demonstrates 
the connection between GABA and these diseases, as in the following case for 
epilepsy. The anticonvulsant actions of benzodiazepines appear to involve the 
enhancement of GABA-mediated inhibition. Also, interference of GABAergic 
function by pharmacological agents ( GAD inhibitors, GABA-receptor blocking 
agents ) or lesions causes seizures, while enhancement of GABA 
( GABA-T inhibitors, benzodiazepines ) protects against seizures ( Olsen 
82).
GABA Metabolism
GABA is synthesized in the GABA shunt, a supplementary closed loop of 
the Krebs cycle that acts to conserve the supply of GABA. Although glucose is 
the principle precursor for GABA synthesis, pyruvate and several other amino 
acids can feed into the GABA shunt. The first step in the GABA shunt is the 
transamination of a-ketoglutarate, an intermediate in the Krebs cycle, to 
glutamic acid. Glutamic acid is then decarboxylated by glutamic acid
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decarboxylase ( GAD ) and its cofactor pyridoxal phosphate ( PLP, Vitamin B6) 
to produce GABA. Catabolism of GABA occurs through transamination by 
aminobutyrate aminotransferase ( GABA-T ) and PLP to form succinic 
semialdehyde, requiring a-ketoglutarate as acceptor of the amino group. This 
transforms a-ketoglutarate into the GABA precursor glutamate, thus metabolism 
of GABA is accompanied by the formation of its precursor. The succinic 
semialdehyde formed from GABA is quickly oxidized by succinic semialdehyde 
dehydrogenase ( SSADH ) to succinic acid, which reenters the Krebs cycle 
( Figure 2).
Ancillary to the GABA shunt is the glutamine loop. Released GABA taken 
up by glial cells is transaminated by GABA-T as in neural cells. Lacking the 
enzyme GAD, however, glial cells cannot convert glutamate to GABA and 
instead synthesize glutamine, which is returned to nerve endings. There the 
enzyme glutaminase produces glutamate from glutamine, conserving the 
supply of GABA precursor.
The enzymes GABA-T and SSADH are bound to the mitochondria. GAD, 
glutamine synthase, and glutaminase occur in the presynaptic cytoplasm with 
GAD located only in neurons and glutamine synthase only in glia. Interestingly. 
GABA synthesis and degradation do not take place in the same cellular 
compartment.
GABA Receptors and Pharmacology
GABA receptors have been categorized pharmacologically into two types: 
GABAa receptors which are sensitive to bicuculline and insensitive to baclofen, 
and GABAb receptors which are insensitive to bicuculline and activated by 
baclofen ( Bowery 72 ). GABAb receptors are coupled to G proteins and 
probably mediate an inhibition of adenylate cyclase ( Dolphin 84, Bowery 72 ). 
Located presynaptically, this receptor type functions to reduce the release of 
other neurotransmitters by decreasing the inward flux of calcium at the 
presynaptic membrane during an action potential.






























Figure 2. The GABA Shunt. GABA is synthesized 
from glutamate, which is readily available through 
the Krebs cycle. Thus mainstream metabolic 
molecules supply the carbon skeleton for GABA 
metabolism. The final product of GABA 
metabolism, succinate, reenters the citric acid 


























Figure 3. Schematic model of the GABAa receptor
chloride/ionophore complex. Each section of the 
"doughnut” represents a distinct binding site for 
various drugs and endogenous compounds which 
modulate chloride permeability. Adapted from McGee 
& McGee, 1989.
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Binding to this receptor causes a brief ( msec ) increase in chloride 
conductance and shifts the membrane potential towards chloride equilibrium, 
stabilizing the resting membrane potential and inhibiting the target cell 
( Takeuchi 79 ). Three classes of centrally active drugs that modulate GABAa 
receptor function are the picrotoxin-like convulsants that inhibit GABA function, 
and the benzodiazepines and barbiturates which enhance GABA function 
( Haefely 84).
The "doughnut" model in Figure 3 shows the binding sites for these three 
categories of drugs and GABA on the GABA receptor/chloride ion channel 
protein complex ( Olsen 82 ). The GABA receptor site binds the agonist 
muscimol and the antagonist bicuculline. The benzodiazepine receptor site 
binds depressants like diazepam that potentiate GABA mediated inhibition. 
Picrotoxin-like convulsants bind at the picrotoxin site and block GABA-activated 
chloride channels, possibly by binding to the channel itself. Barbiturates and 
related depressants bind at the barbiturate site and are defined by their indirect 
interactions with the three other receptor sites, i.e., phenobarbital inhibits the 
' binding of picrotoxin and GABA, and enhances the binding of benzodiazepines 
(Olsen 82).
All four receptor sites can be assayed by radioactive ligand binding 
followed by ARG. However, only information from experiments using 3H-GABA 
receptor binding are pertinent to interpretation of results in this 
dissertation, and particular attention will be given to those data only, as follows. 
Binding of 3H-GABA is performed on frozen and thawed tissue using sodium- 
free buffer to prevent association of ligand with sodium-dependent uptake sites 
Under these conditions 3H-GABA binding has met many criteria of receptor 
identification such as appropriate affinity, selectivity and specific tissue 
localization ( Olsen 82 ). Most importantly, receptor binding has been shown 
to be inhibited by analogs ( muscimol, bicuculline ) which are active agonists or 
antagonists on GABA synapses but not inhibited by other amino acid analogs 
( 2,4-diaminobutyric acid ), GABA transport inhibitors ( nipecotic acid ), or by 
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Table 2. Drugs that affect GABA action.
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Many other pharmacological agents are known to act on the GABAergic 
system apart from receptor sites and involve classical manipulation of 
neurotransmitter systems. These include agents acting on GABA metabolism, 
presynaptic uptake, synthesis, storage, postsynaptic destruction, and 
postsynaptic activation. Listed in Table 2 are some of the drugs used in this 
dissertation with discussion following below.
The enzymes GAD and GABA-T are both PLP sensitive and are both 
inhibited by antipyridoxal agents, GAD being more vulnerable ( Marley 82). In 
vivo inhibition of GAD by hydrazides will cause a fall in brain GABA levels 
( Marley 82 ). Many compounds effectively inhibit GABA-T; the most common 
drug used experimentally is aminooxyacetic acid. Pharmacologic agents that 
inhibit GABA-T will cause a rise in GABA mediated neural processes.
GABA uptake systems exist in glia as well as in neurons and apparently
are different as they are affected by different inhibitors. p-Alanine is several
hundred times more potent at inhibiting glial GABA uptake than in neurons. 
Conversely, L-DABA effectively blocks neural uptake but weakly affects glial 
uptake.
Review of GABA in Vertebrate Retina 
The techniques of microdissection, autoradiography, electrophysiology, 
and immunohistochemistry have been used extensively to establish GABA as a 
classical neurotransmitter in the retina of vertebrates ( Yazulla 86 ). The 
presence of GABA in retinal neurons has been demonstrated in rabbit ( Voaden 
77, Kuriyama 68, Dick 84 ), rat ( Kennedy 77, Yates 76, Voaden 77 ), frog 
(Yates 76 ), monkey ( Pusateri 84 ), and mudpuppy ( Dick 84 ) by 
microdissection, and in human ( Lam 80, Agardh 87 ), cat ( Wassel 89 ), rabbit 
( Brandon 79, 83; Mosinger 85, 87 ), rat ( Vaughn 78, 81; Lin 83 ), chicken 
( Pasantes-Morales 72 ), frog ( Brandon 79, 83 ), goldfish ( Lam 72, Marc 78, 
Ball 87 ), lizard ( Engbretson 89 ), tiger salamander ( Yang 88 ), primate 
( Agardh 87 ), and hatching quail ( Ball 87 ) by immunohistochemistry.
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Intracellular recordings with pharmacological characterizations have been 
performed in the tiger salamander ( Wu 86, Li 90 ) and goldfish (Ishida 83 ).
The most widely used marker for GABAergic neurons, L-glutamate 
decarboxylase, has been shown to be present in rat ( Lin 83, Vaughn 81 ), 
catfish ( Lasater 84 ), goldfish ( Lam 79, Ball 87), monkey ( Hendrickson 85, 
Nishima 85 ), hatching quail ( Pessac 87 ), rabbit ( Mosinger 87 ), tiger 
salamander ( Yang 88 ) and lizard ( Engbretson 89 ), as well as skate, frog and 
pigeon ( Agardh 87 ) by immunohistochemistry. More recently the technique of 
in situ hybridization has located GAD in human, monkey and cat ( Swarthy 90). 
The degradative enzyme, GABA-transaminase ( GABA-T ), has been localized 
by IHC and microdissection in carp ( Hayashi 81 ), rabbit ( Kuriyama 68 ), 
goldfish ( Lam 75 ), monkey ( Pusateri 84 ), mudpuppy ( Dick 84 ) and rat ( Lin 
83).
In addition to verification of the presence of endogenous substances, 
uptake of 3H-GABA followed by ARG is also used as an anatomical marker for 
GABAergic neurons. As previously stated, high-affinity uptake is assumed to be 
the means for removal of GABA at the synapse to terminate neurotransmitter 
action and to recycle GABA for reuse. 3H-GABA uptake has been studied in 
many species: chicken ( Bauchman 77 ), mouse ( Blanks 82 ), rabbit ( Ehinger 
70, 71, 77 ), cat ( Freed 82, 83; Pourcho 80, 81 ), goldfish ( Lam 71, Marc 78, 
Yazulla 81,84 ), frog ( Voaden 74, Neal 79 ), mudpuppy ( Pourcho 84 ), pigeon 
and chicken ( Marshall 74 ), skate ( Bruun 84 ), tiger salamander ( Li 90 ), rat 
( Marshall 74b, Bruun 74 ), newt ( Ball 83 ), human ( Bruun 74 ), catfish ( Lasater 
84 ), and monkey ( Bruun 74 ). The properties of uptake are similar to that 
observed in rat cerebral cortex ( Yazulla 86 ). These properties include sodium 
and temperature dependence, and inhibition by DABA and nipecotic acid. Both 
high and low affinity uptake mechanisms have been reported.
Data from GABA receptor localization and binding studies lend further 
support to the role of GABA as a neurotransmitter in the vertebrate retina. 
Benzodiazepine receptors have been studied in chick ( Alstein 81, Howells 79 ), 
rat ( Paul 80, Sieghart 82, Robbins 89 ), cow ( Borbe 80, Osborne 80, Richards
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87, Redburn 79 ), sheep and pig ( Enna 76 ), skate ( Malchow 89 ), goldfish 
( Yazulla 89 ), and human ( Richards 87 ). Both GABAa and GABAb receptors 
have been described and each displays features common to GABA receptors 
found in vertebrate brain. GABA binding to GABAa receptors is Na+- 
independent and shows stereospecific inhibition by bicuculline ( Schaeffer 82 ). 
This receptor type is located in pre- and postsynaptic membranes and is 
ordinarily linked to a chloride ionophore ( Madtes 84 ). GABAb receptors are 
insensitive to inhibition by bicuculline, are located presynaptically, and inhibit 
neurotransmitter release ( Schaeffer 82 ).
Comparison of data from anatomical and biochemical studies mentioned 
above reveals a certain degree of mismatch. In particular, 3H-GABA uptake 
sites do not always coincide with IRC of endogenous markers. Double label 
experiments for 3H-GABA uptake and immunoreactivity of GAD did not co­
localize in 10% of the cells ( Studholme 85, Yazulla 85 ). This lack of 
correspondence reached 82% in another study in goldfish amacrine cells 
( Zucker 84 ). However, there is some debate over error due to methodology 
and in the majority of instances where adequate data is available there is good 
agreement. For example, in another experiment on goldfish retina, ARG 
localization of 3H-GABA uptake and IHC localization of GABA and GAD showed 
good agreement. In another study on larval tiger salamander retina, the same 
three markers ^gain showed good correspondence. IHC data for GABA and 
GAD frequently show a good match as has been demonstrated in lizard 
( Engbretson 88 ), rabbit ( Mosinger 85 ), quail ( Pessac 87 ), baboon, monkey, 
and man ( Agardh 87 ), and skate, frog, pigeon, chicken, rabbit, and man 
( Agardh 87 ). The conclusion of these studies is that identification of 
GABAergic neurons in the retina may not be dependent on a single 
morphological datum.
Further verification of GABA as a retinal neurotransmitter can be observed 
from data on release studies. The most appropriate stimulus for retinal neurons 
is light but the most widely used stimuli have been elevated potassium and the
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excitatory amino acids L-glutamate and L-aspartate ( suspected photoreceptor 
neurotransmitters ). The majority of studies have been performed using in vitro 
tissue preloaded with 3H-GABA although more recent experiments measure 
released endogenous GABA by high performance liquid chromatography. 
Results are somewhat conflicting depending on the experimental animal, type 
of stimulus, or source of measured GABA, endogenous or exogenous. In one 
experiment using different stimuli and measuring the release of both 
endogenous and 3H-GABA, K+ mediated release was found to be calcium and 
sodium dependent while L-glutamate and kianate mediated release were Ca+2 
independent and Na+ dependent ( Malchow 89 ). A separate experiment on 
chicken retina showed different characteristics for release using the same 
stimuli ( hi K+ or amino acids ) depending on the GABA source: release of 
endogenous GABA was totally Ca+2 dependent while 3H-GABA release was 
50% Ca+2 dependent ( Campochiaro 84 ). Finally, different animal models gave 
varying results even though each experiment used the same stimulus ( hi K+ ) 
and measured the same product ( endogenous GABA ). Release was shown to 
be Ca+2 independent in toad ( Schwartz 82 ) and goldfish ( Ayoub 84 ) , 
partially Ca+2 dependent in chick ( Compochiaro 84 ), and Ca+2 dependent in 
teleost ( Jaffe 84 ) and Xenopus ( Cunningham 88, 85 ).
Discussion concerning release of retinal GABA has currently centered 
around the possibility that there are several mechanisms for transmitter release 
and that the model of Ca+2 mediated vesicular release represents only one 
type. It has been suggested that GABA may be released by a carrier-mediated 
event driven by Na+ and not Ca+2, similar to the mechanism responsible for 
GABA uptake ( Schwartz 82, Yazulla 83, 85, Ayoub 84 ). This theory is 
supported by the absence of synaptic vesicles in known GABAergic retinal 
neurons in goldfish ( Yazulla 83 ) and by the demonstration in avian retina that 
release of 3H-GABA is Ca+2 independent/ Na+ dependent while 3H- 
acetylcholine release is Ca+2 dependent/ Na+ independent ( deMillo 88 ).
A final criteron to consider for verification of GABA as a retinal 
neurotransmitter is the ability of exogenously applied GABA to stimulate
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postsynaptic neurons at physiological concentrations and the ability of GABA 
antagonists to block the stimulation. Intra- and extracellular recordings of retinal 
tissue have displayed such effects in many animals: mudpuppy ( Miller 81 ), 
tiger salamander ( Marshall 78 ), carp ( Murakami 78 ), catfish ( Lam 78 ), fish 
( Negishi 83 ), frog ( Stone 84 ) and skate ( Lasater 84 ). However, research in 
this field of study has been primarily concerned with the role of GABA in the 
formation of ganglion and bipolar cell receptive fields. While reports are 
abundant and complex, the general consensus is that the inhibitory surround of 
receptive fields is mediated by GABA as well as acetylcholine ( Bonaventure 89, 
Stone 87, Ikeda 83 ).
Review of GABA in Invertebrates 
First reports of GABA in invertebrate nervous systems came from 
experiments demonstrating the inhibitory action of a mammalian brain extract,
" Factor I", on the crayfish stretch receptor ( Florey 54 ). Later, Kravitz and 
colleagues showed GABA to be present in lobster inhibitory neurons, where it 
was synthesized, accumulated, and released ( 65 ). Other early work on GABA 
in arthropods was essentially electrophysiological while the bulk of 
biochemistry on GABAergic neurotransmission was worked out in mammalian 
tissue.
Quantification of GABA has been determined in the nervous system of 
many invertebrate species by many techniques, including gas chromatography- 
mass spectroscopy ( GC-MS ), for example. Concentrations of GABA, 
particularly in insect and crustacean tissue, are comparable to those found in 
mammalian tissue. Levels of GABA as expressed in mM/g wet weight are: 
mouse cortex = 2.4 ( Breer 86 ), lobster ganglion = 0.95 - 3.6 ( Aprison 73 ), 
honeybee brain = 10.9 ( Frontali 64 ), cockroach ganglion = 2.5 ( Ray 64 ).
The synthesis and metabolism of GABA in crustaceans, first worked out by 
Kravitz and colleagues ( 65 ), was found to be similar to that found in 
mammalian nervous systems. Both GAD and GABA-T have been purified from 
insect tissue. GAD has been studied in lobster ganglion ( Molinoff 68 ), crayfish
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brain ( Wu 76 ), honeybee brain ( Fox 72 ), cockroach brain ( Baxter 75 ), and 
locust brain ( Stapleton 86 ). GABA-T has been studied in lobster ( Hall 67 ), 
locust and cockroach brain ( Sugden 77, Breer 86 ).
Uptake of 3H-GABA was first demonstrated in an invertebrate nerve- 
muscle preparation and was found to be sodium dependent ( Iversen 66,
68 ). The same authors also showed that preloaded 3H-GABA could be 
released upon stimulation. Craelius and Fricke ( 81 ) described release of 3H- 
GABA in a calcium-dependent manner from inhibitory neurons innervating the 
muscle receptor organ of crayfish. In a study on cockroach abdominal ganglia, 
uptake was reported as being partially sodium dependent and inhibited by fa- 
alanine ( Hue 82 ).
Vesicles isolated from crayfish neuromuscular tissue showed high-affinity 
uptake which can be inhibited by nipecotic acid and by 2,4-diaminobutyric acid 
( DABA ) ( Meiners 79 ). Synaptosomes from locust nervous tissue show a 
saturable high-affinity uptake mechanism, dependent on sodium and chloride 
ions ( Gordon 82 ). Locust synaptosomes display both high-affinity and low- 
affinity GABA uptake systems , the former system exhibiting sodium 
dependency and inhibition by DABA and nipecotic acid ( Breer 80 ). Cockroach 
neuronal cultures also show a sodium-dependent, high-affinity uptake for GABA 
( Lees 86).
Fewer studies of GABA receptors have been done on invertebrates than 
on mammals. The earliest work involved binding studies on shrimp muscle 
which showed sensitivity to bicuculline and muscimol ( DeRobertis 74 ). Further 
studies on GABA receptors have been performed on locust ganglia ( Robinson 
86 ), housefly head ( Lunt 85 ), honeybee brain ( Abalis 86 ), cockroach CNS 
( Lummis 85 ), and crayfish muscle ( Meiners 79 ). One difference found 
between mammalian and insect GABA receptors is a variability in sensitivity to 
bicuculline ( Lunt 88 ).
Another difference noted between some invertebrate and mammalian 
GABA receptors is the absence of a benzodiazepine receptor binding site. This 
site was absent in five invertebrate species studied ( earthworm, squid,
28
woodlouse, lobster and locust) ( Nielsen 78 ). Other studies have shown 
sensitivity to benzodiazepine agonists and antagonists in cockroach brain 
( Lummis 87 ) and locust ( Robinson 86 ). Picrotoxin, however, exhibits very 
potent and specific binding to GABA receptors ( Robinson 88 ). In conclusion, it 
can be said that GABA receptor complexes in insects are similar in overall 
organization to their mammalian counterparts ( Robinson 88 ).
GABA as a Neurotransmitter in Invertebrate Eyes 
Research concerning GABA in invertebrate vision has been centered on 
insects, as has been true of studies described in the previous section. Using 
monoclonal antibodies to GABA, Myer ( 86 ) and colleagues described positive 
cells and fibers in the optic lobes of a fly, Musca, and a bee, Apis. Datum, et al. 
( 86 ), also used IHC techniques to identify GABAergic neurons in R7 
photoreceptors and C2 centrifugal fibers in the blowfly visual system. In 
Manduca sexta, cells positive for GABA were located in optic lobe interneurons 
( Homberg 87 ). Fuller and colleagues ( 89 ) described GABA-like 
immunoreactive neurons in all three optic neuropil regions of a cockroach.
Two other studies involved uptake of 3H-GABA by insect optic lobes. 
Campos-Ortega ( 74 ) used ARG to localize uptake of tritiated GABA in the 
lamina ganglionaris of the flies Musca and Drosophila. In this investigation 
uptake was confined to glial and not neural cells. However, Frontali, et al.
( 73 ), localized uptake in neuronal cells and cellular processes in cockroach 
eyes.
Review of GABA Uptake, Vertebrate Nervous Tissue 
Studies on the uptake of GABA have been performed primarily on 
mammalian (rat) brain slices and synaptosomes and to a lesser degree on 
retinal tissue. The experimental technique involves incubation of the tissue in 
question in a bathing solution containing H3-GABA, C^-GABA or a Cn- 
precursor, followed by light microscope autoradiography.
The function of uptake is the removal of neurotransmitter from the synaptic
29
cleft to terminate its physiologic effect (Iverson 71 ). Uptake also conserves 
transmitter for reuse. The assumption of autoradiographic trace experiments is 
that labeled uptake sites are structures that already contain endogenous GABA.
The system responsible for uptake has the characteristics of an active 
transport system: saturable, sodium-dependent, temperature sensitive, and 
metabolically dependent as shown by inhibition of uptake by ouabain 
(Iverson 65 ) and picrotoxin ( Burkhardt 75 ). The high-affinity membrane 
carrier is also specific for GABA ( Bead 72 ).
Experiments typically show two transport systems for GABA ( as is also 
true for several other neurotransmitters ), one called high-affinity ( Km in the mM 
range ) and the other called low-affinity ( Km in the mM range ). The high-affinity 
uptake system is thought to be unique and is the one involved in transmitter 
termination (Iverson 73 ). Uptake sites have been located at nerve terminals 
and cell bodies ( Weitsch-Dick 78 ). The low-affinity system, associated with 
both neuroactive and inactive amino acids , exhibits broader specificity and is 
sodium- and temperature-independent ( Lajtha 75, Logan 71 ).
The mechanism for GABA transport is similar to that for sugars. The 
mechanism implies a carrier-mediated coupling between the transport molecule 
and the inward movement of sodium ions along their electrochemical gradient. 
That is, the transport of amino acids/sugars against their concentration gradient 
is linked to downhill passive movement of sodium, while a separate transport 
mechanism for sodium, the Na+/K+-ATPase system, maintains the necessary 
sodium gradient ( Weinstein 65 ). Therefore the direction and magnitude of 
amino acid transport depends on the direction and magnitude of the 
electrochemical sodium gradient.
Among substances used to further understand GABA uptake are 2,4- 
diaminobutyrate ( L-DABA ), nipecotic acid, and b-alanine. L-DABA is a GABA 
analogue which is taken up by neurons but not glia by a high affinity 
mechanism similar to that for GABA (Weitsch 78 ). b-Alanine does the reverse; 
it uses a high-affinity uptake system in glia but not in neurons ( Schon 75 ). On
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the other hand nipecotic acid is a potent inhibitor of uptake by both glia and 
neurons ( Schousboe 78 ).
A second mechanism for uptake of transmitter was proposed by Levi 
( 72 ) and Simon ( 73 ) based on the observation that amino acid transport 
systems can mediate exchange in addition to net transport. This process of 
homoexchange can reversibly exchange amino acids across the membrane 
with no net uptake. The homoexchange mechanism has characteristics of high- 
affinity uptake, i.e., saturation kinetics, temperature sensitivity, and sodium 
dependence. However, several experiments challenging the homoexchange 
theory have shown a net uptake of radioactive GABA rather than exchange 
( Roskoski 78).
Review of GABA Release, Vertebrate Neural Tissue.
Experiments on release of GABA have been performed primarily on rat 
brain slices, synaptosomes and, to a lesser degree, on isolated retina. The 
most frequently used technique has involved preloading the tissue with 
radiolabeled GABA and perfusing the tissue with a variety of solutions. The 
largest percentage of experiments on GABA release has been studied using 
high extracellular K+ concentrations ( hi K+ ), with later work using HPLC 
analysis. The dependency of release on external Ca+2 is well established for 
acetylcholine, catecholamines, serotonin and a few other putative 
neurotransmitters ( Kelly 79, Raiteri 84 ). However data concerning GABA 
release and Ca+2 dependency is less clear. For example, in brain slices, 
stimulus-induced release of GABA has shown no dependency on Ca+2 
( Katz 69, Srinivasan 69, Okada 73, Orrego 76 ), partial Ca+2 -dependency 
( Redburn 76, Szerb 79, Lockerbie 85, Caudill 85, Maurin 85, Arias 86, Peris 
87 ), or hi Ca+2-dependency ( Hammerstadt 72, Potashner 78, Moroni 81, 
Limberger 86, Orrego 86, Bernath 89 ).
Release of tritiated GABA has also been shown to be affected by addition 
of GABA to perfusion solutions. Ouabain, a Na+ / K+ - ATPase inhibitor, also 
stimulates GABA release. Interpretation of this data has suggested the
31
existence of several independent mechanisms for release as well as several 
pools of releasable neurotransmitter.
A most likely mechanism for GABA release is via the classical pathway, 
involving calcium mediated exycotosis of vesicular stores. Calcium- 
independent release, as well as ouabain and GABA stimulated release, is likely 
to occur from cytoplasmic stores, either through a hypothetical amino acid 
channel or by reversal of the Na+ -cotransport, carrier-mediated system that is 
responsible for GABA uptake. The latter, rather than being calcium dependent, 
is sodium dependent as Na+ is the driving force for GABA transport across the 
membrane. It is also interesting to note that potassium-evoked, calcium 
dependent release of labeled GABA has been shown in glial tissue ( Minchin 
74, Sellstrom 77 ) and that this release in not sodium dependent.
General Anatomy of the Grapsid Eye
The general neural organization of the eye of Hemigrapsus nudus 
includes an outer retinal layer and four successive optic lobes. The compound 
retina consists of several thousand ommatidia, each formed by eight retinula 
cells concentrically arranged and a distal crystalline cone. An outer cornea 
provides a protective barrier between the visual elements and external 
environment.
Retinula cell axons at the basal end of ommatidia penetrate a basement 
membrane and collect into bundles. Just beneath the basement membrane is 
an extensive number of vascular channels ( hemocoelic cavity ) filled with 
hemolymph, through which retinula axon bundles traverse. It is believed that 
axons project to particular optic cartridges in the first two optic lobes, preserving 
the spatial organization of retinula ommatidia ( Stowe 77, Stowe and Leggett 
78).
The four successive optic lobes are the lamina ganglionaris, medulla 
externa, medulla interna, and medulla terminalis, followed by an optic nerve 
( see Photo 1 ). Neural organization within the optic lobes is not well 
understood. In general, axons project between lobes and laterally within each
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lobe, ultimately sending afferents which collect to form the optic nerve as well as 
receiving efferents through the optic nerve ( Rafuse, personal communication ).
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Photo 1. Transverse section of whole eye, Hemigrapsis nudus. 1. Distal 
Ommatidia containing Retinular cells. 2. Hemocoelic cavity with axon bundles. 
3. Lamina Ganglionaris. 4. Medulla Externa. 5. Medulla Interna. 6. Medulla 




Crabs ( Hemigrapsus nudus) were chilled, eyestalks removed and the
whole eye dissected. Care was taken to remove muscle and connective tissue 
with minimal damage to neural tissue. Eyes were incubated under conditions of 
discontinuous agitation at 10°C for 20 minutes in 200 jil of crab Ringer’s 
solution ( NaCI= 480 mM; CaCl2= 6 mM; MgCl2= 10 mM; KCI= 9 mM; NaHC03= 
4 mM; glucose= 5 mM; Aminooxyacetic acid = 0.1 mM ), pH=7.4, with 2 pi 3R- 
GABA ( specific activity= 29.3 Ci/mM; New England Nuclear) and 100% O2. 
Following incubation, eyes were rinsed in two 5 minute changes of Ringers 
without [3HJ-GABA and were processed either for light microscope 
autoradiography (LM ARG) or biochemical studies.
Light Microscope Autoradiography. As a control, eyes were processed as 
stated above but incubated separately in crab Ringer's solution without [3H]- 
GABA, then treated as follows. Eyes were fixed overnight ( 3% glutaraldehyde, 
2% formaldehyde in PIPES buffer, pH=7.2 ), then either embedded in paraffin- 
butylmethacrylate ( 0.2 g benzoyl peroxide, 3.5 g paraffin, 10 ml 
butylmethacrylate ) or osmicated, bloc stained in p-phenylenediamine and 
embedded in Epon 812. Sections (1 pm thick, Epon, and 5 pm thick, 
paraffin/butylmethacrylate ) were dipped in Kodak NTB-2 nuclear track 
emulsion and exposed at 4°C for 2 weeks. They were developed in Kodak D- 
19 at 18°C and butylmethacrylate sections were stained with H&E and 
coverslipped.
BIOCHEMISTRY: Uptake and Release. The effects of several ions, chemicals, 




Crabs weighing 45-50 g were used in all uptake experiments. Eyes 
were preincubated for 20 minutes at 10°C in 200 jil crab Ringer's solution with 
the added chemical or altered ion concentration and without [3H]-GABA. A 
similar solution was used for the postincubation wash. The effect of Na+ on 
uptake of pHJ-GABA was tested by substituting NaCI with equimolar 
concentrations of LiCI and adjusting pH with KOH. In other ion assays, CaCl2 
and KCL were not replaced. The calcium free Ringers contained EGTA (1 
mM ). Various drugs ( Sigma Chemical Co., St. Louis, Mo.) and GABA 
analogues were tested for their effect on uptake by addition to preincubation, 
incubation, and wash solutions: Nipecotic acid (1 mM ), ouabain ( 40 pm ), non­
radioactive GABA ( 1 mM ), B-alanine (1 mM ), 2,4 diaminobutyrate ( L-DABA )
(1 mM ), bicuculline (1 mM ), picrotoxin (1 mM ), verapamil (10 pM ), 
nifedipine (10 pM ), cytochalasin B ( 20 pM ), and colchicine (10 pM ). To 
examine the effect of temperature on uptake, normal incubating solutions were 
used and preincubation, incubating and wash solutions were strictly maintained 
at the tested temperature. In all experiments, after post-incubation wash, eyes 
were digested for two days at 4°C in 1.0 mi of a 0.02% trypsin-HEPES solution. 
After vortexing, the whole eye digest was diluted with scintillation cocktail. The 
radioactivity was determined by liquid scintillation spectroscopy ( Beckman 
Model LS 5801, Beckman Instruments Division, Berkeley, CA ). Background 
and quenching corrections were made.
Release of label was observed by perfusion technique. Eyes were 
allowed to accumulate label as described in methods for uptake, placed on filter 
paper in a perfusion chamber, and perfused with normal or altered Ringers at a 
rate of one ml/min. Fractions were collected at 2 minute intervals. Radioactivity 
of the perfusate, filter ( soaked overnight in 1.0 ml Ringers ), and trypsin- 
digested eyes was determined by liquid scintillation spectroscopy to determine 
the total radioactivity in each eye at the onset of an experiment. Results were 
reported in two forms. The first, reported as disintegrations per minute 
( DPMs ), represents the radioactive count for each 2 minute collection as
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determined by scintillation spectroscopy. The second value, % release, was 
calculated by dividing the DPMs per collection by the total number of DPMs 
determined for the eye at the onset of the experiment.
Release experiments examined spontaneous release by using normal 
crab Ringers or Ringers lacking the test ion in the post incubation wash and 
perfusate solutions. As in uptake experiments, sodium free Ringers contained 
an equimolar amount of LiCI as a substitute and calcium free Ringers contained 
1 mM EGTA.
For analysis of evoked release, eyes were perfused for 26 minutes with 
normal Ringers followed by a high potassium perfusate ( 30 mM, 60 mM, and 90 
mM K+ Ringers ) for 6 minutes before returning to the previous perfusate. To 
examine the effect of Na+ or Ca+2 on K+ -evoked release, eyes were washed 
then sequentially perfused with Ringers lacking the ion, pulsed by switching 60 
mM K+ Ringers perfusate, ending with the original ion deficient Ringers. The 
same time tables were used for normal K+ and high K+- Cytoskeletal 
experiments were performed by the addition of either 20 pM cytochalasin B or 
10 pM colchicine to wash and perfusates.
Data was examined statistically by the Mann-Whitney test.
Immunohistochemistry
Eyes were dissected from their exoskeleton and fixed in 4% 
paraformaldehyde in 0.1 M phosphate buffer ( pH 7.4 ) for 1 hr. followed by an 
overnight fix in 4% paraformaldehyde in phosphate buffer. After fixation, eyes 
were washed in phosphate buffer, dehydrated and embedded in paraffin. 
Immunocytochemical staining of GABA was carried out on paraffin sections (10 
pM thick) using the PAP technique. Tissue was covered with the following 
solutions:
3% H2O2 ,10 min., room temp.
Normal goat serum ( Sigma Chemical Co., St. Louis, Mo.) 1:10 in 
phosphate buffered serum ( PBS ), pH 7.4, 20 min., room temp. 





with PBS, overnight in moist chamber, room temp.
Anti-rabbit IgG goat serum 1:20 in PBS, 1 hr., room temp.
Fresh 3,3-diaminobenzidine-4 HCL ( DAB ), 30 min. Prepared as 
follows: 33jil of 30% H2O2 to 100 ml of 0.05% DAB ( 50g DAB-4- 
HCL in 100 ml PBS ).








i. The Effect of Ions
The effect of eliminating Na+, K+, or Ca+2 on uptake was assayed by 
omitting each ion from the preincubation, incubation and wash solutions. The 
absence of K+ had no significant effect on uptake, the absence of Ca+2 caused a 
slight decrease in uptake, and the omission of Na+ showed a marked decrease 
in uptake ( Figure 4 ). A graded reduction of Na+ in the test solutions showed 
the effect on uptake to be dose dependent ( Figure 5 ). The decreased uptake 
observed with the omission of Ca+2 was (1 ) restored by the addition of 1 mM 
Ca+2 and ( 2 ) matched in degree the reduced uptake with the addition of the 
calcium channel blockers verapamil and nifedipine ( Figure 6 ).
ii. Temperature Effect
The influence of temperature on 3H-GABA uptake was monitored by carrying 
out the assay at several temperatures between 0°C and 15°C ( Figure 8 ). 
Maximum uptake occurred at 10°C, the normal habitat temperature for H. 
nudus. At 5°C there was a clear cut decrease in uptake with further decrease in 
uptake at 0°C. Experiments performed at 15°C also caused a decrease in 
uptake.
iii. The Effect of Inhibitors
When added to the test solutions, the metabolic inhibitors nipecotic acid and 
ouabain decreased uptake by crab eyes by more than 50% ( Figure 7 ). Other 
inhibitors known to interact with different components of the GABAergic system 
were tested for their effect on uptake: unlabeled GABA, 2,4-diaminobutyric acid
( L-DABA ), (3-alanine, bicuculline, and picrotoxin ( Figure 9 ). Uptake was
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strongly inhibited by cold GABA and L-DABA, moderately inhibited by (3-alanine 
and not affected by bicuculline or picrotoxin.
iv. Effect of Cytoskeletal Toxins
Cytochalasin B and colchicine were tested for their influence on the uptake of 
3H-GABA by addition of these chemicals to the preincubation, incubation and 
wash solutions. Neither drug demonstrated any significant effect ( Figure 10 ).
II. 3H-GABA Release 
i. Resting Release
Release of label from preloaded eyes perfused with normal Ringers was 
plotted as % of total radioactivity released into each 2 minute perfusate for 60 
minutes ( Figure 11 ). Initial radioactivity of release was high and was followed 
by a lower, more uniform basal release. Because the initial phase of release 
was considered to be washout of extracellular 3H-GABA, subsequent analysis 
of release was confined to perfusates collected after 18 minutes.
When perfused with sodium free Ringers, release of label was uniform, 
decreasing slightly with time ( Figure 12 ). When the perfusate was changed at 
30 minutes to normal Ringers and at 40 minutes to sodium free Ringers, no 
change in the amount of release was observed. A similar pattern of release 
was seen when a calcium free Ringers perfusate was used ( Figure 13 ).
The curves describing release from eyes perfused with either normal 
Ringers, sodium free Ringers or calcium free Ringers were superimposed 
( Figure 14 ). Each curve was similar in shape and in % of label released.
ii. Evoked Release of Label
a. Effect of K+ Concentration
K+ evoked release of label was assayed using 30 mM, 60 mM, and 90 
mM K+ Ringers ( Figures 15,16, and 17 respectively ). In each curve a clear cut 
increase in amount of label released was observed when perfusate was
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changed to hi K+ Ringers. K+ evoked release was also shown to be dose 
dependent ( Figure 18 ). Evoked release was demonstrated with two, 4 minute 
pulses of 60 mM K+ Ringers ( Figure 19 ). In this assay, the release of label from 
the second dose of hi-K+ was somewhat lower than that released by the first 
pulse.
b. Effect of Ions
The effect of using calcium free Ringers on evoked release was tested 
( Figure 20 ). When compared to the curve for evoked release with normal 
Ringers, evoked release with calcium free Ringers was reduced in amount. 
Both curves were alike in shape. A similar effect was seen with sodium free 
Ringers ( Figure 21 ).
c. Effect of Cytoskeletal Toxins
The influence of cytochalasin B and colchicine on K+ -evoked release of 
label was assayed ( Figures 22 and 23 ). Comparison with the curve for evoked 
release by normal Ringers showed no difference in the amount of label 
released with either drug.
Autoradiography and Immunohistochemistry
Examination of LM ARG slides revealed a dense pattern of label over 
several restricted cells, demonstrating the ability of a certain population of cells 
to accumulate and retain exogenous 3H-GABA. Positive cells were located in 
the lamina ganglionaris and medulla externa of crab optic lobes and label was 
seen over cell bodies, axon fibers and nerve terminals ( Photos 2, 3 and 4 ).
The medulla intermedia and medulla interna were negative ( Photos 7 and 8 ). 
Photo 1 of retinular cells and Photo 2 of axon bundles in the hemocoelic cavity 
were also both negative. However ARG observations in these two regions were 
not included in the final evaluation as the similarity of retinal melanin granules 
in size and color to ARG grains would have made analysis inconclusive.
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Examination of IHC slides revealed similar patterns of labeling. Retinular 
cells and hemocoelic axons ( Photos 9 and 10 ) did not stain by the PAP 
method, while the lamina ganglionaris and medulla externa did stain ( Photos 
11 and 12 ). The medulla intermedia and medulla interna were also negative 












Normal No K+ No Na+ No Ca+2
3H-GABA Uptake
Figure 4. Effect of excluding individual ions from the incubation
medium on the uptake of 3H-GABA by crab eyes. Each bar 
represents the mean ± SEM of at least 6 experiments. See 
Tables 3 and 10 for data. p1 =0.5152, p2=0.0011, 
p3=0.0011.
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Figure 5. Effect of the reduction of sodium ion in the incubation 
medium by 0%, 25%, and 50% on the uptake of 3H- 
GABA by crab eyes. Each experiment is the mean ± 













Normal NoCa 1mMCa 2mMCa Verap. Nifedip.
3H-GABA Uptake
Figure 6. Effect of omission of Ca+2, replacement of Ca+2 in 
1 mM increments, and addition of calcium channel 
blockers verapamil (10 pM ) and nifedipine ( 10 pM ) 
to incubation medium on the uptake of 3H-GABA by crab 
eyes. Each bar represents the mean ± SEM of at least 6 
experiments. See Tables 3, 5, and 10 for data. 















Figure 7. Effect of metabolic inhibitors nipecotic acid ( 1 mM )
and ouabain (10 jiM ) on the uptake of 3H-GABA by crab 
eyes. Each bar represents the mean ± SEM of at least 6 
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Figure 8. Effect of varying incubation temperature
on the uptake of 3H-GABA by crab eyes. Each 
point is the mean ± SEM of at least 6 experiments. 










Normal GABA L-DABA 3-Ala Bicuc. Piero.
3H-GABA Uptake
Figure 9. Effect of the addition of several chemicals to the 
incubation medium on the uptake of 3H-GABA by 
crab eyes. The concentration of all chemicals 
was 1 mM. Each bar represents the mean ± SEM 
of at least 6 experiments. See Tables 8 and 10
for data. L-DABA = 2,4-diaminobutyrate; p-Ala = p- 
Alanine; Bicuc = Bucuculline; Piero = Picrotoxin. 
















Figure 10. Effect of the addition of cytoskeletal toxins cytochalasin 
B ( 20 jiM ) or colchicine (10 jiM ) to the incubation 
medium on the uptake of 3H-GABA by crab eyes. Each 
bar represents the mean ± SEM of at least 6 
experiments. See Tables 9 and 10 for data. Cyto. B = 
Cytochalasin B; Colch = Colchicine. p1 =0.0126, 
p2=0.017.
50









0 T T T T T T
0 10 20 30 7040 50 60
Time (min)
Figure 11. Release of label by crab eyes preloaded with 3H-GABA 
and perfused for 60 minutes with normal crab Ringers. 
Each point is the mean ± SEM for 6 experiments. See 
Tables 11 and 14 for data.
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Resting Release, Ringers With and Without Sodium
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Figure 12. Release of label by crab eyes preloaded with 
3H-GABA and perfused alternately with normal 
crab Ringers and Ringers in which an equimolar 
amount of LiCI was substituted for NaCI. Each 
point is the mean of 4 experiments, SEM = 0.10- 
0.15. See Tables 11 and 14 for data.
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Figure 13. Release of label by crab eyes preloaded with 3H-GABA 
and perfused alternately with normal crab Ringers and 
calcium free Ringers. Each point is the mean of 4 
experiments, SEM = 0.06 - 0.10. See Tables 13 and 14 
for data.
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Figure 14. Overlay of curves from Figures 11,12, and 13 
comparing the effects of sodium and calcium 
ions on the release of label from preloaded 
crab eyes.
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Figure 15. Evoked release of label from preloaded crab eyes 
by 30 mM K+ Ringers. Eyes were perfused with 
normal Ringers for 26 minutes, pulsed for 6 minutes 
with Hi K+ Ringers, then perfused again with normal 
Ringers. Norm K+ = Normal Ringers; Hi K+ = 30 mM 
K+ Ringers.
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Figure 16. Evoked release of label from preloaded crab eyes with 
60 mM K+ Ringers solution. Eyes were perfused for 26 
minutes with normal crab Ringers solution then pulsed 
for 6 minutes with Hi K+ Ringers before returning to 
normal Ringers perfusate. Each point is the mean ± SEM 
of 4 experiments. Norm K+ = normal K+ Ringers; Hi K+ = 
60 mM K+ Ringers.
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Figure 17. Evoked release of label from preloaded crab eyes with 
90 mM K+ Ringers solution. Eyes were perfused for 26 
minutes with normal crab Ringers then pulsed with HI K+ 
Ringers before returning to normal Ringers perfusate. 
Each point is the mean ± SEM of 4 experiments. Norm 
K+ = Normal K+ Ringers; Hi K+ = 90 mM K+ Ringers.
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Figure 18. Base and peak points from Graphs 12, 13, and 14 were 
used to evaluate % release above baseline for each 
concentration of K+ evoke. R=0.95.
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Figure 19. Crab eyes preloaded with 3H-GABA were perfused
with normal crab Ringers and pulsed twice for 4 minutes 
at perfusion times 26 min and 36 min. Each point is the 
mean ± SEM of 4 experiments. See Tables 19 and 21 for 
data. N Ring = Normal Ringers, Hi K+ = 60 mM K+
Ringers.
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Figure 20. Potassium-evoked release of label from preloaded 
crab eyes using Ringers perfusate with and without 
calcium. In the upper curve, eyes were perfused 
with normal Ringers for 26 minutes, then pulsed with 
60 mM K+ Ringers for 6 minutes. In the lower curve, 
eyes received the same treatment except the 
Ringers contained no calcium.
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Figure 21. Potassium-evoked release of label from preloaded 
crab eyes using Ringers perfusate with and without 
sodium. In the upper curve, eyes were perfused with 
normal Ringers for 26 minutes, then pulsed for 6 
minutes with 60 mM K+ Ringers. In the lower curve, 
eyes received the same treatment except NaCI in 
the Ringers solution was replaced with an 
equimolar amount of Lid.
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K+ Evoked Release of Label from Crab Eyes 
Perfused with Ringers with and without Cytochalasin B
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Figure 22. Graph showing the effect of cytochalasin B ( 20 jiM ) 
on the potassium-evoked release of label from 
preloaded crab eyes. In the upper curve ( clear 
triangles ) eyes were perfused with normal Ringers 
and pulsed with 60 mM K+ Ringers. In the lower 
curve ( black triangles ) all perfusates, normal and 
Hi K+ ( 60 mM ) Ringers, contained cytochalasin B.
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0 T T T
10 20 30 40 50
Time ( min.)
Figure 23. Effect of colchicine ( 10 jiM ) on the potassium-evoked 
release of label from preloaded crab eyes. The curve 
of clear triangles shows the release of label from eyes 
perfused and pulsed ( 60 mM K+ ) with normal Ringers. 
In the curve of black triangles, eyes were perfused and 
pulsed ( 60 mM K+ ) with Ringers containing 10 pM 
Colchicine.
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Photo 2. Retinular cells did not show grain counts above background levels.








































Photo 5. Cells in the lamina ganglionaris with positive labeling.
Photo 6. Positively labeled axon fibers in the medulla externa.
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Photo 7. Labelling of medulla intermedia cells did not exceed background 
levels. Embedded in paraffin/butylmethacrylate.
Photo 8. Medulla interna cells had the same level of activity as the background 




Photo 9. Retinular cells do not show endogenous GABA by an 
immunohistochemical technique.
Photo 10. Immunohistochemistry shows that there is no endogenous GABA in 





Photo 11. Axons in the lamina ganglionaris are labeled for endogenous GABA 
by immunohistochemistry.




Photo 13. There was no immunohistochemical marker for endogenous GABA 
in the medulla intermedia cells.
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DISCUSSION
Light Microscope Autoradiography and 
Immunohistochemistry
Autoradiography was used as an anatomical marker for GABAergic 
neurons and positive cells were found in the lamina ganglionaris and medulla 
externa. Certain biochemical experiments concerned with uptake were
performed to verify LM ARG labeling patterns. p-Alanine and L-DABA were 
used to differentiate between glial and neural labeling. Others have shown that 
L-DABA inhibits uptake of GABA by neurons but not glia whereas p-AIanine 
preferentially inhibits glial uptake ( Schon 74, Bowery 78 ). Inhibition of uptake 
by L-DABA resembled that caused by unlabeled GABA and the level of uptake 
found in p-Alanine eyes was only slightly less than that found in normal eyes,
indicating that the ARG labeling primarily involved neural tissue ( Figure 9 ).
The possibility of false labeling due to surface receptor binding was 
studied using bicuculline and picrotoxin. Since neither chemical reduced 
uptake it is unlikely that ARG grains reflected postsynaptic receptor binding. 
Further support for this conclusion was given by the dependence of uptake on 
sodium, as receptor binding is sodium-independent ( Greenlee 78 ). Use of the 
chemicals discussed above for elucidation of ARG grain patterns is unique to 
this study. References in the literature to bicuculline and picrotoxin discuss 
pharmacological effects on behavior, GABA receptor characterization, and 
postsynaptic electrophysiology (Bowery 72, Dolphin 84, Olsen 82, Matsumoto
89). p-Alanine and L-DABA have been used to describe mechanisms and 
selectivity of uptake in comparison with GABA ( Yazulla 86 ).
IRC was used as a second anatomical marker. Results were in 
agreement with ARG findings and located endogenous GABA in specific cells of 
the lamina ganglionaris and medulla externa. Because sectioning was not 
identical from eye to eye or between the two experiments, it cannot be stated
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that the same cells tested positive in the ARG and the IHC techniques.
However, the general location of positive cells within each optic lobe was the 
same, suggesting that uptake of 3H-GABA occurred in structures already 
containing endogenous GABA.
To date no studies have been reported using both ARG and IHC markers 
in invertebrates. Reports on vertebrate retina comparing the results of these two 
markers generally showed good agreement ( Engbretson 88, Mosinger 85, 
Agardh 87 ) although some mismatch has been described ( Studholm 85, 
Yazulla 85, Zucker 84 ). Possible causes of mismatch could be uptake of 3H- 
GABA by non-neural cells or IHC labeling of antigens other than GABA, neither 
of which occurred in this study.
Neurochemistry
UPTAKE
One mode for the termination of GABA activity is reuptake into nerve 
terminals or glial cells; accordingly active transport systems have been found in 
vertebrate and invertebrate preparations which accumulate GABA via a high 
affinity carrier-mediated transport system as described by Ereckinska ( 87 ) and 
Yazulla ( 86 ). According to the model, the transport mechanism consists of a 
carrier-mediated coupling between the uptake of GABA and the movement of 
sodium into the cell down its electrochemical gradient. A separate Na+/K+ 
dependent ATPase acting as an ion pump maintains the necessary sodium 
gradient. Results from this paper suggest that the optic lobes in Hemigrapsus 
nudus possess an uptake system with similar properties.
First, a metabolic link to uptake was established. The nearly linear 
relationship between uptake and temperature in the range from 0°C and 10 °C 
( Figure 8 ) is contrary to that predicted for simple diffusion. The decrease in 
uptake at 15 °C is probably due to tissue morbidity as crabs do not survive at 
that warm temperature. Inhibition of uptake by metabolic toxins nipecotic acid 
and ouabain further support an energy dependent system. Second, uptake is 
dependent on sodium in a dose-dependent manner ( Figures 4 and 5 ). As
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suggested above, sodium supplies the energy and direction for transport.
Finally, for all experiments the concentration of 3H-GABA in the incubation 
solution was in the 10-8 m range. This concentration is sufficient to interact with 
high-affinity uptake systems ( Km = 10-6 M range for GABA ), and is too low to 
interact with lo-affinity systems ( Km = 10-3 M ) known to transport amino acids. 
The evidence indicates that GABA uptake occurs through a high-affinity 
metabolically active, sodium dependent system in H. nudus.
A somewhat surprising result was the amount of uptake 0°C, in the 
absence of sodium, or when the ratio of unlabeled GABA to 3H-GABA was 106 
to 1. Apparently accumulation of label occurred to some degree even during 
the cessation of metabolic processes, without the aid of downhill movement of 
sodium, or during conditions of high competitive inhibition. Possibly label 
entered by diffusion and was retained by the cells by subsequent trapping of 
GABA into metabolic processes. This hypothesis is supported by the 
comparatively high degree of inhibition of uptake at 0°C ( 5893 DPM ), a 
condition which arrests all metabolic processes, as contrasted with lesser 
inhibition of uptake due to interference with the co-transport system ( no Na+ =
12,571 DPM; cold GABA = 9953 DPM ) or interference with the Na+ / K+ ATPase 
( nipecotic acid = 15,290 DPM; ouabain = 15,045 DPM ). Analogs and drugs 
mentioned above affected only uptake mechanisms while 0°C depressed all 
metabolism. The lower DPMs seen in 0°C eyes may have been due to the 
added effect of blocking retention of 3H-GABA into metabolic pathways.
Calcium was also seen to play a role in uptake, since calcium free test 
solutions caused some decrease in uptake ( Figure 4 ), an effect reversed by 
the addition of only 1 mM of calcium ( Figure 6 ). A similar decrease in uptake 
caused by verapamil and nifedipine ( Figure 6 ) suggests that the influence of 
calcium on uptake, unlike sodium, occurs inside the cell rather than at the 
membrane. Since calcium regulates many neurotransmitter processes at the 
synapse, its effect on uptake is possibly related to one of its control activities.
The possibility that calcium affects tubulin and actin was tested because 
of its regulatory role in the classical model for neurotransmitter transport and
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release in which these cytoskeletal elements are involved. However, neither 
cytochalasin B, which prevents actin polymerization ( Korn 82 ), nor colchicine, 
which depolymerizes microtubules ( Augustine 86 ), modified uptake ( Figure 
10 ). Either actin and tubulin do not play a role in uptake of GABA in crab eyes 
and calcium affects other synaptic activities or these experiments were 
ineffective in revealing the role of calcium, actin and tubulin on uptake. There 
are no reports in the literature assaying the affect of a calcium free test medium 
on 3H-GABA uptake.
Release
Demonstration of GABA release in response to stimulus is an important 
step in establishing a transmitter role for GABA. The use of high concentration 
of potassium in the external medium is a technique widely used in vitro to mimic 
the reactions occurring in vivo in nervous tissue during neuronal activity.
Release was examined in two parts, resting or spontaneous release which 
occurred during perfusion with Ringers having normal potassium concentration 
and evoked or stimulated release which occurred during perfusion with Ringers 
having high potassium concentration.
Normal resting release was determined by perfusing preloaded eyes 
with normal crab Ringers solution ( Figure 11). The initial high rates of release 
which declined very rapidly may represent washout of label from extracellular 
spaces, from surface binding or from damaged cells. The second phase of 
sustained baseline release may have had contributions from several sources. 
Tissue pathology induced during dissection or experimentation may have given 
rise to a slow disintegration of tissue. Possibly a nonspecific efflux of label from 
tissue occurred via amino acid carriers or via simple diffusion. Another 
possibility was the activation of transmitter-release mechanisms by some 
unidentified stimulant. And finally, there may be some contribution from glial 
tissue as resting release of transmitter has been reported in other neural 
preparations ( Schrier 74 ).
Basal release of transmitter has been observed in numerous and diverse
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preparations, including release of endogenous GABA from retinal preparations 
( Campochiaro 84 ) and quanta! release of acetylcholine as determined by 
postsynaptic recordings of miniature end plate potentials at the myoneural 
junction. It is therefore likely that a portion of release of label observed in the 
second phase reflects a normal physiological process, namely the steady 
release of transmitter in the absence of an action potential or membrane 
depolarization.
Further experimentation demonstrated the insensitivity of spontaneous 
release to the absence of calcium or sodium, eliminating some possible 
mechanisms ( Figure 14 ). Since calcium has an important regulatory function 
in vesicular-mediated exocytosis, this was apparently not the mechanism for 
resting release. Likewise, it is unlikely that release was mediated by a reversal 
of the sodium-driven uptake mechanism. In addition, these two experiments 
reduced the likelihood that an unidentified stimulant was a contributor to 
baseline release since these two ions play an important role in evoked release 
( Figures 20 and 21, discussed below ).
Potassium-evoked release was clearly demonstrated using 30mM, 60 
mM, and 90 mM concentrations of potassium. Release was dose dependent as 
higher concentrations of potassium caused a greater amount of release of label. 
When perfused with two successive pulses of elevated potassium, the increase 
in release of label resulting from the second pulse was less than that generated 
by the first pulse ( Figure 19 ). It is possible that there was a decreased pool of 
releasable transmitter after the first pulse due to interference of reuptake by 
continuous flow perfusion. Under normal in vivo conditions one would not 
expect fatigue, given the 6 minute time lapse between pulses. No reports were 
found in the literature regarding release of 3H-GABA pulsed twice with high 
concentrations of potassium.
Potassium-evoked release showed calcium-dependent and calcium- 
independent components. The calcium-dependent component may reflect 
vesicular-mediated exocytosis while calcium-independent release may have 
involved a different pool of releasable transmitter, perhaps from non-vesicular
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cytoplasmic sources. These results do not mean that GABA can be released 
independently of calcium since free calcium might be available to release sites 
from intraneural ( mitochondria, endoplasmic reticulum ) pools of calcium. The 
literature on the effects of removal of external calcium on GABA release is 
abundant and the results are mixed. In vertebrate brain slices and vertebrate 
retina many examples of absolute dependence, no dependence, and partial 
dependence on calcium for release were found ( see pages 26 and 32 for a 
review ). Only one report on invertebrate tissue has been made in which 
calcium dependent release of 3H-GABA from peripheral inhibitory neurons was 
demonstrated ( Craelius 81 ).
Methodology may be a source of some inconsistency in the data.
Different stimuli to the same tissue can show a difference in calcium 
dependency for release ( Malchow 89 ). Other reports using the same stimuli 
found differences in calcium dependence between release of 3H-GABA and 
endogenous GABA ( Compochiaro 86 ). Finally, use of the same stimuli and 
measurement of the same source of GABA showed variations in calcium 
dependence for different animals. For example, release was calcium 
independent in toad ( Schwartz 82 ) and goldfish { Ayoub 84 ), partially 
dependent in the chicken ( Compochiaro 86 ), and dependent in fish ( Jaffe 84 ) 
and frog ( Cunningham 85, 88 ).
Further evidence suggesting separate mechanisms for release from 
different pools is the requirement of sodium in K+ evoked release. Reversal of 
the sodium-driven uptake mechanism may be responsible for sodium- 
dependent evoked release of 3H-GABA from a non-vesicular cytoplasmic pool, 
a release mechanism first suggested by Simon ( 74 ). Others have found a 
similar dependence on sodium for release of 3H-GABA (Raiteri 75, Yazuila 83b, 
Malchow 89 ) while some have not ( Cunningham 81, de Millo 88 ). When 
considered in conjunction with results discussed in the preceding paragraph, 
these data of calcium-dependent, calcium-independent, and sodium-dependent 
components suggest separate pools of transmitter being released by separate 
mechanisms. Interestingly an altogether different mechanism may be
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responsible for spontaneous release, which is independent of either calcium or 
sodium ( Burgess 87 ).
Some of the evoked release may have been artifactual. 3H-GABA taken 
up by cells may not have equilibrated with endogenous GABA and non- 
physiological compartmentalization may have occurred. Also, there is no 
assurance that all release occurred at terminals, as may be the case with 
calcium-independent release. Potassium-evoked release of 3H-GABA by glial 
tissue has been described and it is not known whether release mechanisms for 
glial tissue are the same as those described from neural tissue. Although 
uptake experiments described in this paper suggest that glial uptake of 3H- 
GABA is small, release from these cells may have obscured events occurring at 
nerve terminals.
Experiments were designed to test the involvement of cytoskeletal 
elements in the release process. In the classical model of transmitter release, 
microtubules are involved in transport of newly synthesized transmitter from 
sites of synthesis to the vicinity of release and F-actin is associated with the 
docking of vesicles at synaptic terminals until release occurs ( Aunis 88, Gray 
83 ). The model predicts that cytoskeletal toxins should facilitate release due to 
removal of inhibition to diffusion by vesicular transport and docking. However, 
disruption of normal actin and tubulin polymerization, assumed to occur by the 
addition of cytochalasin B and colchicine to sample solutions, did not affect 
potassium-evoked release of label from crab eyes ( Figures 22 and 23 ).
Failure to show cytoskeletal involvement may be due to experimental design 
since the 3H-GABA that accumulated during uptake may not have needed 
transport to synaptic sites and may not have been vesicular.
Reports in the literature for the effects of colchicine and cytochalasin B 
are mixed. For example, studies disrupting F-actin polymerization in 
permeabilized chromaffin cells showed increase ( Lelkes 86 ), no effect 
( Knight 82 ), and decreased catecholamine release ( Bader 83 ).
Morphological studies verifying disassembly of F-actin and microtubules in 
conjunction with evoked release data could clarify these results.
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In conclusion, data presented in this paper support the role of GABA as a 
putative neurotransmitter in the optic lobes of the eye of the crab H. nudus. 
Evidence includes the presence of a high-affinity, sodium-dependent, 
metabolically active uptake mechanism, location of endogenous GABA in 
specific neurons, and the ability to release 3H-GABA. This study is the first to 
establish GABA as a putative neurotransmitter in the eye of an invertebrate, the 
decapod Hemigrapsus nudus.
Summary of Data
Criteria for Classification Results
of Substance as
Neurotransmitter.
1. Substance contained in 
neurons from which it is 
released.
GABA was located in the two distal optic 
lobes by IHC and ARG.
ARG grain patterns were determined to be 
intracellular. Inhibition of uptake by L-DABA 
was similar to that caused by GABA, while 
p-Alanine inhibition was slightly less than 
normals.
ARG label was shown to be intracellular. 
Picrotoxin and Bicuculline did not reduce 
uptake.
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2. Demonstrate Ca+2 
dependent release.
Demonstrated dosed dependent release 
by elevated K+. Release was partially Ca+2, 
partially Na+ dependent.
Demonstrated non-evoked release of label. 
Release was Ca+2 and Na+ independent.
Evoked release did not involve cytoskeletal 
elements F-actin and tubulin, as determined 
cytochalasin B and colchicine.
3. Demonstrate mechanism 
of inactivation.
Demonstrated uptake of GABA by ARG and 
characterized uptake mechanism as a high- 
affinity Na+dependent, metabolically active 
process.
Three of the six criteria required for the classification of a substance as a 
neurotransmitter were satisfied, establishing GABA as a putative transmitter in 
the optic lobes of Hemigrapsus nudus.
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32,416 12,460 36,131 23,417
31,014 31,28010,986 25,862
38,591 12,003 30,203 23,416





Table 3. Results in DPMs of uptake of 3H-GABA
by crab eyes incubated in normal crab Ringers 
solution or Ringers without either sodium, potassium 
or calcium. Experiments performed under normal 
conditions were testedlOX, while variant conditions 













Table 4. Data in DPMs of uptake of 3H-GABA by
crab eyes incubated in crab Ringers in which 
a percentage of normal NaCI concentration 










40,742 33,202 16,246 21,973
28,724 36,012 19,552 19,154
29,940 26,160 25,13030,606
31,101 28,048 24,899 24,101
29,055 29,248 20,646 22,103
33,855 32,606 24,785 24,747
Table 5. Uptake of 3H-GABA by crab eyes incubated in crab
Ringers solution with reduced calcium concentration or 
with the addition of calcium channel blockers Verapamil 
or Nifedipine (10 jiM ).
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Table 6. Uptake in DPMs of 3H-GABA by crab eyes









Table 7. Uptake in DPMs of 3H-GABA
by crab eyes incubated in crab Ringers 
with metabolic inhibitor Nipecotic acid 
(1 mM ) or Ouabain (10 pM ).
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GABA 6-Alanine BicucullineL-DABA Picrotoxin
10,371 11,838 26,041 36,017 31,829
10,422 15,021 26,950 35,436 37,101
12,102 28,0229995 35,717 33,976
9954 31,8629560 30,650 33,446
8303 13,188 30,123 28,808 28,191
8570 32,462 31,16811,430 26,430
Table 8. Data in DPMs of uptake of ^-GABA by crab eyes incubated 
in crab Ringers containing one of the following chemicals : 
unlabeled GABA (1 mM ), L-DABA ( 1 mM ), 6-Alanine ( 1 mM) 








Table 9. Uptake of ^-GABA in DPMs by crab eyes incubated
in crab Ringers with cytotoxin Cytochalasin B ( 20 pM ) or 
Colchicine (10 pM ).
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Incubating Conditions MEAN SEM
Normal Ringers 33,551 919
Ringers, no Na+ 12,571 575
Ringers, 25% Na+ 19,178 673
Ringers, 50% Na+ 24,918 809
Ringers, no K+ 31,725 1495
Ringers, no Ca+2 23,925 1375
Ringers, 1 mM Ca+2 243031,456
Ringers, 2 mM Ca+2 30,928 1684
Verapamil 22,726 2061
Nifedipine 23,426 1321
Nipecotic Acid 15,290 666
Ouabain 85215,045
Temp = Q°C 5893 267
Temp = 5°C 17,991 566






Cytochalasin B 37,147 1237
Colchicine 38,433 1332
Table 10. Mean and SEM for all uptake experiments, derived 
from data contained in Tables 3 through 8.
Time
(min)
Perfusate N1 N2 N3 N4
DPM %Rel DPM %Rel DPM %Rel DPM %Rel
20 Ring, no Na+ 480 1.45 650 1.621.76 607 693 1.93
22 Ring, no Na+ 470 1.42 639 1.73 632596 1.59 1.91
24 Ring, no Na+ 457 1.38 628 1.70 577 622 1.881.54
26 Ring, no Na+ 430 1.30 610 1.65 566 1.51 616 1.86
28 Ring, no Na+ 602 1.62431 1.30 1.83551 1.47 606
Ring, no Na+30 420 1.27 598 1.62 536 1.43 596 1.80
32 Norm Ring 1.21401 584 1.58 532 1.42 579 1.75
Norm Ring34 1.18 525391 565 1.53 1.40 573 1.73
Norm Ring36 367 5811.11 1.57 562506 1.35 1.70
38 Norm Ring 1.32 556 1.681.00 554 1.50 495331
Norm Ring40 328 0.99 539 1.46 491 1.31 571 1.73
Ring, no Na+42 314 0.95 528 1.281.43 480 533 1.61
Ring, no Na+44 308 0.93 517 472 1.261.40 513 1.55
Ring, no Na+46 230 0.89 516 1.40 450 1.20 1.49493
Ring, no Na+48 301 0.91 499 442 1.181.35 495 1.49
Ring, no Na+50 298 5020.90 420 1.12 1.421.36 470
Table 12. Release of label from crab eyes preloaded with 3H-GABA and perfused alternately 
with normal crab Ringers and Ringers in which NaCI was replaced with an 
equimolar amount of LiCI. Norm Ring = Normal Ringers; Ring no Na+ =
Ringers without NaCI. CD
Time
(min)
Perfusate N1 N2 N3 N4
DPM %ReI DPM %Rel DPM %Rel DPM %Rel
Ring, no Ca+220 724 1.80 749 1.95 563 1.78 525 1.48
22 Ring, no Ca+2 708 1.76 730 1.90 554 1.75 518 1.46
24 Ring, no Ca+2 688 1.71 722 1.88 544 1.72 1.42504
26 Ring, no Ca+2 672 707 1.841.67 535 1.69 493 1.39
28 Ring, no Ca+2 660 1.64 696 1.81 522 4861.65 1.37
Ring, no Ca+230 648 1.61 669 1.74 519 4791.64 1.35
32 Norm Ring 640 1.59 657 1.71 1.62 472513 1.33
Norm Ring34 623 1.55 634 1.65 503 1.59 461 1.30
36 Norm Ring 615 1.53 630 4841.64 1.251.53 444
38 Norm Ring 607 1.51 615 4711.60 1.49 1.24440
40 Norm Ring 595 1.48 1.57603 470 429 1.211.49
42 Ring, no Ca+2 583 5801.45 4521.51 4221.43 1.19
Ring, no Ca+244 571 1.42 581 1.51 421433 1.37 1.19
Ring, no Ca+246 567 1.41 561 4211.46 4121.33 1.16
Ring, no Ca+248 555 1.38 550 418 1.321.43 415 1.17
Ring, no Ca+250 547 1.36 546 1.42 411 1.30 405 1.14
Table 13. Release of label from crab eyes preloaded with3H-GABA and perfused 
alternately with normal crab Ringers and calcium free Ringers. Norm 




Perfusate K+ M NZ. UZ N4
(mM) DPM %Rel DPM %Rel DPM %Rel DPM %Rel
20 Norm Ring 5629 1.61 617 1.261.45 391 827 1.83
22 Norm Ring 532 1.529 596 372 1.201.40 799 1.77
24 Norm Ring 9 539 1.54 587 1.38 782354 1.14 1.73
26 Norm Ring 9 514 1.47 579 1.36 335 1.08 772 1.71
28 Hi K+ Ring 30 703 2.01 745 1.75 472 1.52 2.381075
Hi K+ Ring30 30 752 2.15 2.361004 574 1.85 1292 2.86
32 Hi K+ Ring 30 566 1.62 821 357 980 2.171.93 1.15
Norm Ring34 5529 1.58 562 1.32 351 1.13 773 1.71
Norm Ring36 9 511 1.46 575 1.35 344 1.11 736 1.63
Norm Ring38 9 493 1.41 511 1.20 307 7180.99 1.59
Norm Ring40 9 472 1.35 498 2851.17 0.92 714 1.58
Table 15. Evoked release of label from preloaded crab eyes by 30 mM K+ Ringers 
solution. Norm Ring = Normal Ringers; Hi KT^Ring = 30 mM K+Ringers; 





Perfusate K+ N1 N2 N3 N4
(mM) DPM %Rel DPM %Rel DPM %Rel DPM %Rel
20 Norm Ring 9 820 2.10 583 1.35 1.86711 490 1.19
22 Norm Ring 9 813 2.04 566 1.31 677 1.77 473 1.15
24 Norm Ring 9 793 1.99 1.26544 657 1.72 453 1.10
26 Norm Ring 9 765 1.92 545 1.26 623 4201.63 1.02
28 Hi K+ Ring 60 968 2.43 920 2.13 692 1.81 700 1.70
Hi K+ Ring30 60 1199 3.01 1226 2.84 917 2.40 1021 2.48
Hi K+ Ring32 60 841 2.11 760 1.76 623 1.63 589 1.43
Norm Ring34 7409 1.86 574 1.33 573 4081.50 0.99
Norm Ring36 9 746 1.87 544 1.26 577 1.51 379 0.92
38 Norm Ring 6989 1.75 514 1.421.19 543 391 0.95
Norm Ring40 6829 1.71 497 3421.15 501 0.831.31
Table 16. Evoked release of label from preloaded crab eyes by 60 mM Kf Ringers 
solution. Norm Ring = Normal Ringers; Hi K^Ring = 60 mM K+Ringers; 




Perfusate K+ N1 N2 N3 N4
(mM) DPM %Rel DPM %Rel %RelDPM DPM %Rel
20 Norm Ring 6839 1.77 451 884 2.011.39 1.62590
22 Norm Ring 9 667 1.73 425 844 1.921.31 575 1.58
24 Norm Ring 9 644 1.67 406 1.25 2.08915 586 1.61
26 Norm Ring 1.589 610 380 1.17 827 1.88 593 1.63
28 Hi K+ Ring 90 1316 3.41 1035 3.19 1632 3.71 2.891139
Hi K+ Ring30 162890 4.22 1220 17203.76 16423.91 4.51
Hi K+ Ring32 829 2.1590 500 8461.54 717 2.321.63
Norm Ring34 9 629 1.63 357 7701.10 1.75 502 1.38
Norm Ring36 9 606 1.57 344 1.06 743 1.69 491 1.35
Norm Ring38 9 613 1.59 318 0.98 739 1.68 451 1.24
Norm Ring40 5529 1.43 308 0.95 748 1.70 433 1.19
Table 17. Evoked release of label from preloaded crab eyes by 90 mM Ringers 
solution. Norm Ring = Normal Ringers; Hi K Ring = 90 mM K*Ringers; 





30 mM K+ 90 mM K+
SEMMean SEM SEMMean Mean
20 1.54 0.12 0.211.63 1.70 0.13
22 1.47 0.12 1.57 0.21 1.63 0.13
24 1.45 0.12 1.52 0.21 1.65 0.17
26 1.40 1.13 1.46 0.20 1.57 0.15
28 1.91 0.18 2.02 0.16 3.15 0.17
2.3030 0.21 2.72 0.16 3.78 0.17
32 1.72 0.22 1.73 0.14 1.91 0.19
34 1.44 1.42 0.180.13 1.47 0.14
36 1.39 1.39 0.200.11 1.42 0.14
38 1.30 0.13 1.33 0.17 1.37 0.16
40 1.25 1.25 0.180.14 1.32 0.16
Table 18. Mean and SEM of data from Tables 15, 16, and 17.
Time
(min)
Perfusate N1 N2 N3 N4
DPM %Re! DPM %Rel DPM %Rel DPM %Rel
20 Norm Ring 510 1.35 652 720 1.721.51 395 1.43
22 Norm Ring 487 1.29 1.48641 707 3891.69 1.41
24 Norm Ring 457 1.21 629 1.46 1.53640 365 1.32
26 Norm Ring 446 1.18 561 1.37 615 1.47 345 1.25
Hi-K+ Ring28 555 8251.47 8501.91 2.03 478 1.78
Hi-K+ Ring30 1035 2.74 1140 2.64 1231 2.94 591 2.14
32 Norm Ring 510 1.35 777 1.80 682 1.63 434 1.57
Norm Ring34 483 1.28 730 1.69 645 1.54 403 1.46
36 Norm Ring 1.20453 617 6281.43 3621.50 1.31
Hi-K+ Ring38 570 1.51 678 1.57 720 1.72 414 1.50
Hi-K+ Ring40 1.68635 786 1.82 833 1.99 1.81500
42 Norm Ring 540 6481.43 1.50 724 1.73 417 1.51
Norm Ring44 502 1.33 596 1.38 1.52636 387 1.40
Table 19. Evoked release of label from preloaded crab eyes given two pulses of 60 mM K+ 
Ringers. Norm Ring = Normal Ringers; Hi K+Ringers = 60 mM K+Ringers;










SEM SEMMean SEMMean Mean
30 2.30 0.211.46 0.13 64 5.6
2.7260 1.46 0.20 860.16 5.9
90 3.781.60 0.15 0.17 136 4.1
Table 20. The mean and SEM of baseline and peak points from Figures 
15,16, and 17 were used to calculate the % above baseline 

















Table 21. Mean and SEM of data from Table 19.
Time
(min)
Perfusate N1 N2 N3 N4
DPM %Rel DPM %Rel DPM %Rel DPM %Rel
Ring, no Ca+220 482 1.25 526 1.14 727934 1.73 1.65
22 Ring, no Ca+2 1.20 525463 1.14 923 1.71 714 1.62
Ring, no Ca+224 443 1.15 508 902 6871.10 1.67 1.56
Ring, no Ca+226 432 1.12 471 1.02 880 1.63 673 1.53
28 Hi K+, no Ca+2 1.21 628467 8021.36 1053 1.95 1.82
Hi K+, no Ca+230 443 1.15 660 1.43 1512 2.80 2.171194
32 Hi K+, no Ca+2 424 563 1.22 1.811.10 977 775 1.76
Ring, no Ca+234 409 1.18 8581.06 544 1.59 679 1.54
Ring, no Ca+236 416 1.08 508 1.10 869 1.521.61 670
Ring, no Ca+238 382 0.99 475 1.03 853 1.58 657 1.49
Ring, no Ca+240 372 4680.94 0.97 804 6211.49 1.41
Table 22. Release of label from preloaded crab eyes perfused with calcium free 
Ringers then pulsed with 60 mM K+Ringers without calcium. Ring,no 
Ca+2= calcium free Ringers; Hi K+,no Ca+2= 60 mM K*"Ringers 





Perfusate N1 N2 N3 N4
%RelDPM DPM %Rel DPM %Rel DPM %Rel
Ring, no Na+20 588 1.69 793 1.021.35 460 902 1.83
22 Ring, no Na+ 571 7521.64 1.28 446 0.99 863 1.75
24 Ring, no Na+ 546 1.57 753 1.28 428 8430.95 1.71
26 Ring, no Na+ 539 1.55 676 1.15 419 0.93 789 1.60
28 Hi K+,no Na+ 1.84640 764 5281.30 1.17 843 1.71
Hi K+,no Na+30 748 2.15 922 1.57 600 1.981.33 976
Hi K+,no Na+32 553 1.59 717 1.22 514 1.14 754 1.53
Ring, no Na+34 522 1.50 492693 1.18 1.09 715 1.45
Ring, no Na+36 508 1.46 670 4551.14 1.01 675 1.37
Ring, no Na+38 1.42494 629 1.07 419 0.93 656 1.33
Ring, no Na+40 452 1.32 582 0.840.99 379 587 1.19
Table 23. Evoked release of label from preloaded crab eyes perfused with sodium 
free Ringers then pulsed with 60 mM K+Ringers without sodium.
Ring, no Na+ = sodium free Ringers ; Hi K +Ring = 60 mM K+Ringers 





Perfusate N1 N2 N3 N4
DPM %Rel DPM %Rel DPM %Rel DPM %Rel
Ring ( Gyot B )20 423 1.22 556 4231.74 1.22 556 1.74
Ring ( Cyto B )22 413 1.19 530 1.66 413 1.19 530 1.66
24 Ring ( Cyto B ) 396 1.14 527 1.65 396 5271.14 1.65
Ring ( Cyto B )26 375 1.08 499 1.56 1.08375 499 1.56
Hi-K+ Ring ( Cyto B )28 771 2.22 2.62741 2.22771 741 2.62
Hi-K-f Ring ( Cyto B )30 874 2.52 773 2.72 874 2.52 773 2.72
Hi-K+ Ring ( Cyto B )32 2.14534 1.54 683 2.14534 6831.54
Ring ( Cyto B )34 521 1.50 649 2.03 521 1.50 649 1.94
Ring ( Cyto B )36 458 1.32 620 1.94 458 1.32 620 1.94
Ring ( Cyto B )38 454 1.31 569 1.78 454 569 1.781.31
Ring ( Cyto B )40 1.27441 562 1.76 127 562441 1.76
Table 24. Evoked release of label from preloaded crab eyes perfused with Ringers containing 
cytochalasin B ( 20 p.M ) then pulsed with 60 mM Ringers containing Cytochalasin 
B ( 20 pM ). Ring ( Cyto B ) = Ringers with Cytochalasin B; Hi-K+Ring = 60 mM K+ 









Mean SEM Mean SEM
20 1.48 0.22 1.52 0.16
22 1.38 0.18 1.42 0.16
24 1.32 0.17 1.40 0.16
26 1.23 0.15 1.38 0.14
28 2.27 2.150.16 0.07
2.4730 2.450.13 0.09
32 1.84 0.18 1.66 0.09
34 1.61 1.480.13 0.09
36 1.48 0.13 1.34 0.08
38 1.43 0.13 1.24 0.08
40 0.151.36 1.28 0.08



































Table 28. List of abbreviations.
